etoposide has been researched along with Neoplasm Metastasis in 334 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 54 (16.17) | 18.7374 |
1990's | 103 (30.84) | 18.2507 |
2000's | 81 (24.25) | 29.6817 |
2010's | 86 (25.75) | 24.3611 |
2020's | 10 (2.99) | 2.80 |
Authors | Studies |
---|---|
Han, XM; Hu, W; Li, C; Li, X; Li, ZY; Shen, YM; Wu, JF; Xia, QH; Yang, L | 1 |
Economidou, SC; Fotopoulos, G; Vrontis, K | 1 |
Dandulakis, M; Mayer, R; Richards, S; Roque, DM; Staats, PN | 1 |
Chorath, J; Gong, J; Guan, M; Hendifar, A; Kamrava, M; Klempner, SJ; Nassir, Y; Nissen, N; Placencio-Hickok, VR | 1 |
Kakuda, Y; Katagiri, H; Miyagi, M; Murata, H; Takahashi, M; Wang, Y; Wasa, J | 1 |
Adra, N; Albany, C; Cary, C; Chovanec, M; Einhorn, LH; Foster, RS; Hanna, NH; Masterson, TA; Snavely, A; Taza, F | 1 |
Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
Chen, L; Gao, M; He, K; Li, J; Pan, Y; Shao, D; Shi, T; Yang, X; Zhang, F; Zhang, M; Zhao, J; Zhao, Y; Zheng, X | 1 |
Afchain, P; Baudin, E; Desgrippes, R; Hadoux, J; Hautefeuille, V; Lepage, C; Lorgis, V; Monterymard, C; Scoazec, JY; Thuillier, F; Tougeron, D; Walter, T | 1 |
Duan, W; Kong, W; Miao, J; Shen, L; Su, L; Wang, M; Wu, Y; Xu, X | 1 |
Alijas, S; Alonso, MJ; Bouzo, BL; Conejos-Sánchez, I; de la Fuente, M; Jatal, R; Lores, S | 1 |
Birtle, A; Chowdhury, K; Harland, S; Huddart, R; Joffe, JK; Marshall, MR; Mazhar, D; Sarker, SJ; Shamash, J; Vinnicombe, S; White, J; Wilson, P | 1 |
Aparicio, T; Baudin, E; Bonnet, I; Cadiot, G; Coriat, R; Dahan, L; Desauw, C; Guimbaud, R; Hentic, O; Le Malicot, K; Lecomte, T; Legoux, JL; Lepage, C; Lepère, C; Lombard-Bohas, C; Malka, D; Manfredi, S; Roquin, G; Scoazec, JY; Thirot-Bidault, A; Tougeron, D; Walter, T | 1 |
Albany, C; Chovanec, M; Hahn, N; Taza, F | 1 |
Bonanno, L; Castiglione, F; Cavanna, L; Costanzo, R; Daniele, G; Di Maio, M; Favaretto, AG; Filipazzi, V; Gallo, C; Gebbia, V; Gridelli, C; Maiello, E; Maione, P; Morabito, A; Perrone, F; Piazza, E; Piccirillo, MC; Rocco, G; Rossi, A; Sandomenico, C | 1 |
Chen, X; Wang, XX; Xue, LW; Yin, DD | 1 |
Bang, SM; Chang, H; Kim, JH; Kim, JW; Kim, MJ; Kim, SH; Kim, YJ; Lee, JO; Lee, JS; Lee, KW | 1 |
Celik, B; Demirag, MK; Elmali, M; Gulel, O | 1 |
Genta, S; Ghisoni, E; Giannone, G; Milani, A; Mittica, G; Montemurro, F; Valabrega, G | 1 |
Chen, J; Fan, Y; Hong, R; Ma, F; Ou, K; Sang, D; Wang, J; Xu, B; Yuan, P; Zhai, X; Zhao, C | 1 |
Alcalde-Ruiz, E; Catala-Mora, J; Chantada, GL; Croxatto, JO; Dabezies, AP; de Dávila, MTG; Dufort, G; Fandiño, AC; Kopp, K; López, JP; Ossandon, D; Parareda-Salles, A; Pérez, V; Ravindranath, Y; Reaman, G; Rey, G; Sampor, C; Suñol, M; Urbieta, M; Zelter, M | 1 |
Khalid, N; Shah, D | 1 |
Assie, G; Baudin, E; Berruti, A; de Krijger, R; Dekkers, OM; Else, T; Fassnacht, M; Haak, HR; Mihai, R; Terzolo, M | 1 |
Fein, DE; Mathew, P; Paulus, JK | 1 |
Aguiar, S; Batista, RMSS; de Cássio Zequi, S; Lopes, A; Mourão, TC | 1 |
Breitbach, GP; Costa, SD; Juhasz-Boess, I; Kuhn, W; Sklavounos, P; Solomayer, EF; Tempfer, C; Veith, C | 1 |
Abboud, MR; Abou Ali, B; Akel, S; Boulos, F; El-Solh, H; Ghanem, KM; Haidar, R; Muwakkit, SA; Saab, R; Saghieh, S; Salman, M; Tamim, H | 1 |
Dumas, I; Ferrer, L; Guillem, P; Lattuca-Truc, M; Levra, MG; Moro-Sibilot, D; Pinsolle, J; Ruckly, S; Timsit, JF; Toffart, AC; Villa, J | 1 |
Chalasani, P; Livingston, RB; Reed, D; Segar, JM; Stopeck, A | 1 |
Masamba, L; Mtonga, P; Mwafulirwa, K; Nyirenda, R | 1 |
Aggarwal, N; Agrawal, M; Chopra, S; Rana, SS; Raveendran, A; Sikka, P; Suri, V | 1 |
Ganti, AK; West, WW; Zhen, W | 1 |
Jamil, K; Naidu Madireddy, UR; Natukula, K; Pingali, UR; Suresh Attili, VS | 1 |
Bompas, E; Clarisse, B; Cojocarasu, O; Delva, R; Eymard, JC; Guillot, A; Houede, N; Joly, F; Leconte, A; Lheureux, S; Linassier, C; Mourey, L; Oudard, S; Ravaud, A; Ringensen, F; Sevin, E; Tubiana-Mathieu, N; Valenza, B; Vedrine, L | 1 |
Bastide, C; Bruyère, F; Deville, JL; Flechon, A; Guy, L; Karsenty, G | 1 |
Bulanov, A; Fedyanin, M; Garin, A; Mosyakova, Y; Pokataev, I; Polockii, B; Tjulandin, S; Tryakin, A; Zakharova, T | 1 |
Cai, S; Shi, A; Yu, R; Zhu, G | 1 |
Aksoy, S; Alkis, N; Arpaci, E; Babacan, N; Budakoglu, B; Cihan, S; Oksuzoglu, B; Seber, ES; Urun, Y; Yalcin, BC; Yetisyigit, T; Yildirim, N; Zengin, N | 1 |
Blower, PJ; Diocou, S; Fruhwirth, GO; Mullen, GE; Ng, T | 1 |
Belada, D; Berková, A; Bolomská, I; Burešová, L; Campr, V; Klener, P; Kozák, T; Kubáčková, K; Matuška, M; Pirnos, J; Přibylová, J; Pytlík, R; Sýkorová, A; Trněný, M; Vášová, I | 1 |
Bellefqih, S; Benjaafar, N; Kebdani, T; Khalil, J; Mezouri, I | 1 |
Albert, I; Ao-Baslock, A; Berger, MS; Blakely, LJ; Kazarnowicz, A; Kovacs, P; Langer, CJ; Moezi, MM; Pajkos, G; Pathak, AK; Ross, HJ; Schnyder, J; Schreeder, MT; Somfay, A; Zatloukal, P | 1 |
Aieta, M; Bosso, D; Buonerba, C; Cobelli, OD; De Placido, S; Di Lorenzo, G; Federico, P; Ferro, M; Imbimbo, C; Izzo, M; Longo, N; Perri, F; Policastro, T; Puglia, L; Vittoria Scarpati, GD | 1 |
Arslan, D; Bozcuk, H; Coskun, HS; Goksu, SS; Gunduz, S; Mutlu, H; Ozdogan, M; Savas, B; Tatli, AM; Uysal, M | 1 |
Chevreau, C; Culine, S; Delva, R; Eymard, JC; Fizazi, K; Fléchon, A; Geoffrois, L; Gravis, G; Habibian, M; Journeau, F; Kerbrat, P; Laplanche, A; Linassier, C; Logothetis, C; Malhaire, JP; Mardiak, J; Martin, AL; Pagliaro, L; Reckova, M; Rolland, F; Roubaud, G; Theodore, C | 1 |
Chen, L; Gu, X; Guo, J; Zhang, WH; Zhang, Y | 1 |
Anurathapan, U; Choeyprasert, W; Chuansumrit, A; Hongeng, S; Nartthanarung, A; Pakakasama, S; Sirachainan, N; Songdej, D | 1 |
Furr, JR; Mellis, AM; Slobodov, G | 1 |
Ferracini, M; Sahu, RP; Travers, JB | 1 |
Boonyapipat, S; Rattanaburi, A; Supasinth, Y | 1 |
Bassett, R; Champlin, R; Gulbis, AM; Holmberg, L; Jones, RB; Kingham, A; Ledesma, C; Margolin, K; Nieto, Y; Pagliaro, L; Tannir, N; Tu, SM | 1 |
Benson, C; Jones, RL; Judson, I; Kasper, B; Khabra, K; Kollàr, A; Langer, R; Miah, A; Noujaim, J; Thway, K | 1 |
Qian, Y; Wang, S; Wang, Z; Wu, Y; Zhang, H; Zhu, R; Zhu, Y | 1 |
Ferrari, S; Serra, M | 1 |
Abe, T; Fujita, K; Kimakura, M; Kiuchi, H; Nagahara, A; Nonomura, N; Uemura, M | 1 |
Bacon, CL; Bracken-Clarke, D; Browne, PV; Conneally, E; Daly, PA; Flynn, C; Gardiner, N; Hayden, PJ; Kennedy, MJ; Lee, G; McCaffrey, J; Ni Chonghaile, M; O'Donnell, DM; O'Kane, G; Power, D; Vandenberghe, E | 1 |
Baser, E; Cetinkaya, N; Gungor, T; Irkkan, C; Korkmaz, E; Yakut, HI | 1 |
Diao, W; Jiang, X; Yu, P | 1 |
Becatti, M; Bianchini, F; Calorini, L; Calvani, M; Chiarugi, P; Giannoni, E; Taddei, ML | 1 |
Altena, R; Bongaerts, AH; de Vries, EG; den Hollander, MW; Gietema, JA; Lubberts, S; Meijer, C; Nuver, J; Oosting, SF; Walenkamp, AM; Westerink, ND; Wolf, RF | 1 |
Chanvorachote, P; Chaotham, C; Puchsaka, P | 1 |
Besse, B; Bluthgen, MV; Boutros, C; Fayard, F; Planchard, D; Remon, J | 1 |
Adra, N; Albany, C; Einhorn, LH; Giannatempo, P; Hanna, NH; Necchi, A; Nicolai, N; Pond, GR; Raggi, D; Salvioni, R | 1 |
Braun, F; Burger, M; Catusse, J; Kayser, G; Reichardt, W; Taromi, S; von Elverfeldt, D; Weber, WA; Zeiser, R | 1 |
Gilman, AL; Oesterheld, J | 1 |
Berretta, S; Biassoni, V; Cefalo, G; Collini, P; Favre, C; Ferrari, A; Fossati-Bellani, F; Gandola, L; Giangaspero, F; Luksch, R; Massimino, M; Pecori, E; Pignoli, E; Poggi, G; Pollo, B; Riva, D; Sardi, I; Solero, C; Spreafico, F; Terenziani, M | 1 |
Cao, Y; Feng, FZ; Wan, XR; Xiang, Y; Yang, XY | 1 |
Bénard, J; Duros, C; Gross, N; Meier, R; Mühlethaler-Mottet, A; Raguénez, G | 1 |
DuBois, SG; Grier, HE | 1 |
Giger, OT; Kurrer, M; O'Meara, AC; Schaer, G | 1 |
Adalberto, Bdel P; Aglietta, M; Aliberti, S; Berger, M; Biasin, E; Brach del Prever, A; Eleonora, B; Fagioli, F; Ferrari, S; Franca, F; Francesco, S; Giovanni, G; Grignani, G; Massimo, A; Massimo, B; Saglio, F; Sandra, A; Stefano, F | 1 |
Cagiannos, I; Morash, C | 1 |
Ameen, M; Butler-Manuel, S; Christmas, T; Gray, R; Lindsay, I; Newsom-Davis, T; Papanikolaou, K; Poulter, D; Seckl, M; Townsend, P | 1 |
Bacci, G; Balladelli, A; Briccoli, A; Di Fiore, M; Ferrari, C; Palmerini, E; Rocca, M; Salone, M | 1 |
Grün, R; Koch, B; Tannapfel, A; Vieth, M | 1 |
Alici, S; Benekli, M; Buyukberber, S; Camci, C; Coskun, U; Dane, F; Gumus, M; Kalender, ME; Kaya, AO; Ozturk, B; Sevinc, A; Uncu, D; Yaman, E; Yildiz, R | 1 |
Akaza, H; Kawai, K | 1 |
Arai, K; Fukase, M; Ikarashi, H; Matsushita, H; Takayanagi, T | 1 |
Anderson, JR; Huh, WW; Raney, RB; Rodeberg, D; Teot, L; Yock, T | 1 |
Bui, B; Coindre, JM; Garbay, D; Italiano, A; Kantor, G; Kind, M; Lortal, B; Stoeckle, E; Toulmonde, M | 1 |
Cardenal, F; Cisar, L; Domine, M; Gorbunova, V; Moiseyenko, V; Soria, JC; Szczesna, A; Thomas, M; Zatloukal, P; Zhang, X | 1 |
Ângelo, S; Moreira, JN; Pinto, AC; Simões, S | 1 |
Bartels, U; Bouffet, E; Finkelstein-Shechter, T; Gassas, A; Hawkins, C; Huang, A; Janzen, L; Laura, J; Mabbott, D; Tabori, U; Taylor, M | 1 |
Gruellich, C; Hasskarl, J; Schroettner, P; Waller, CF | 1 |
Bossi, G; Bussolari, R; Calabretta, B; Cesi, V; Ferrari-Amorotti, G; Raschellà, G; Sesti, F; Tanno, B; Tirindelli, D | 1 |
Bassett, MR; Bedolla, G; Campbell, AD; Davis, AT; Koo, HM; Luttenton, CR; Melnik, MK; Monroe, TJ; O'Rourke, TJ; Richardson, PJ; Stein, P; Szczepanek, CM; Truszkowski, KJ; Van Brocklin, MW; Vande Woude, GF; Webb, CP; Yost, KJ | 1 |
Aass, N; Bokemeyer, C; Collette, L; Daugaard, G; De Santis, M; De Wit, R; Dumez, H; Lluch, JRG; Marreaud, S; Schmoll, HJ; Skoneczna, I | 1 |
Kumabe, T; Niizuma, H; Osawa, S; Saito, R; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
Cardesa, T; Cruz, O; de Torres, C; Galván, P; Huguet, R; Mora, J; Parareda, A; Rodríguez, E; Salvador, H; Suñol, M; Torner, F | 1 |
Beuzeboc, P; Culine, S; Deplanque, G; Droz, JP; Fargeot, P; Ferlay, C; Fléchon, A; Gravis, G; Joly, F; Oudard, S; Perol, D; Pouessel, D; Priou, F; Zanetta, S | 1 |
Anderson, H; Bremnes, RM; Cavallin-Ståhl, E; Cohn-Cedermark, G; Dahl, O; Jerkeman, M; Klepp, O; Langberg, CW; Laurell, A; Olofsson, SE; Solberg, A; Ståhl, O; Stierner, U; Tandstad, T; Wahlqvist, R; Wijkström, H | 1 |
Castillo, L; Chantada, GL; Diez, B; Dufort, G; Koop, K; Palma, J; Richard, L; Sampor, C; Sasso, DF | 1 |
Anchisi, S; Bieri, S; Elhfidh, M; Khanfir, K; Matzinger, O; Mirimanoff, RO; Ozsahin, M; Zouhair, A | 1 |
Jeremić, B; Miličić, B; Milisavljevic, S | 2 |
Bouvy, JJ; Braun, JJ; Ruit, JB | 1 |
Horváth, A; Horváth, E; Popşor, S | 1 |
Ardito, A; Berruti, A; Bracarda, S; Del Buono, S; Ferrero, A; Priola, AM; Rossi, G; Sperone, P; Taberna, E; Terzolo, M | 1 |
Lybol, C; Massuger, LFAG; Ottevanger, PB; Sweep, FCGJ; Thomas, CMG; Westerdijk, K | 1 |
Abate, ME; Barbieri, E; Bisogno, G; Daolio, P; Eriksson, M; Fagioli, F; Ferrari, S; Gandola, L; Grignani, G; Hall, KS; Lindholm, P; Luksch, R; Picci, P; Podda, M; Prete, A; Ruggieri, P; Smeland, S; Tamburini, A; Tienghi, A | 1 |
Abeler, VM; Brennhovd, B; Frøen, H; Lehne, G; Madsbu, UE | 1 |
Centen, DW; Lybol, C; Massuger, LF; Ottevanger, PB; Sweep, FC; ten Kate-Booij, MJ; Thomas, CM; Verheijen, RH | 1 |
Aslan, NM; Azrif, M; Fong, KV; Ismail, F; Leong, YK | 1 |
Eitaki, M; Inanami, O; Meike, S; Yamamori, T; Yasui, H | 1 |
Spigel, DR | 1 |
Chen, J; Huang, XY; Tang, J; Yang, Z; Yuan, Z; Zheng, Q | 1 |
Bertina, RM; Osanto, S; van den Hengel, LG; van Steijn-van Tol, AQ; Versteeg, HH | 1 |
Bowman, LC; Douglass, EC; Finegold, MJ; Katzenstein, HM; London, WB; Plaschkes, J; Reynolds, M | 1 |
Douglas, J; Felgenhauer, J; Gooley, T; Hawkins, DS; Kreissman, S; Park, J; Pendergrass, TW; Rowley, SD; Sanders, JE; Thomson, B | 1 |
Funahashi, Y; Nakamura, K; Taniguchi, T; Yoshimatsu, K | 1 |
Han, J; Li, Y; Liu, B; Situ, Z; Wu, J | 1 |
Bökönyi, G; Horváth, A; Kéri, G; Szende, B | 1 |
Eguchi, K; Goto, K; Hojo, F; Kakinuma, R; Kodama, T; Kubota, K; Kunitoh, H; Matsumoto, T; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Tamura, T; Yoshimura, K | 1 |
Chung, HC; Jang, WI; Jeung, HC; Kim, BS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Shin, HJ; Sohn, JH | 1 |
Badenoch, D; Berney, D; Nargund, V; Oliver, RT; Ong, J; Shamash, J | 1 |
Cowlishaw, D; McKendrick, JJ; Mead, GM | 1 |
Arslan, M; Demiray, M; Evrensel, T; Gonullu, G; Kanat, O; Kurt, E; Manavoglu, O; Ozkan, A | 1 |
Braybrooke, JP; Davis, T; Harris, AL; Joel, S; Levitt, NC; Madhusudan, S; Talbot, DC; Turley, H; Wilner, S | 1 |
Gude, RP; Nagarsenker, MS; Rao, SG; Sant, VP | 1 |
Faiss, S; Raue, F; Schaaf, L; Scherübl, H; Zeitz, M | 1 |
Bilgin, T; Kara, HF; Ozan, H | 1 |
Jackson, AS; Plowman, PN | 1 |
Dickman, PS; Donaldson, SS; Fryer, CJ; Gebhardt, MC; Grier, HE; Krailo, MD; Link, MP; Meyers, PA; Miser, JS; Moore, S; Perlman, EJ; Pritchard, DJ; Rausen, AR; Tarbell, NJ; Vietti, TJ | 1 |
Bokemeyer, C; Clemm, C; Gerl, A; Hartmann, JT; Horwich, A; Kanz, L; Kollmannsberger, C; Meisner, C; Oliver, T; Rückerl, CP; Schmoll, HJ; Stenning, S | 1 |
Bae, JH; Chung, BS; Ju, DS; Kang, CD; Kim, DW; Kim, MJ; Kim, SH; Kwon, JK; Um, JH | 1 |
Bonazzi, C; Buda, A; Cantú, MG; Dell'Anna, T; Sacco, S; Urso, M | 1 |
Du, W; Fontana, J; Hussain, M; Vaishampayan, U | 1 |
Ballard, ET; Dickens, DS; Dothage, JA; Heideman, RL; Jubinsky, PT | 1 |
Bergeron, C; Bernard, F; Boneu, A; Bouzy, J; Chastagner, P; Coze, C; Hartmann, O; Michon, J; Perel, Y; Plantaz, D; Rodary, C; Rubie, H; Valteau-Couanet, D | 1 |
Díaz-Montero, CM; McIntyre, BW | 1 |
Ansari, R; Belani, CP; Lee, JS; Lilenbaum, R; Natale, RB; Robert, F; Rowland, K; Socinski, MA; Waterhouse, D | 1 |
Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
Decatris, MP; O'Byrne, KJ; Sundar, S | 1 |
Dunant, A; Le Chevalier, T; Pignon, JP | 1 |
Collette, L; de Mulder, PH; de Prijck, L; de Wit, R; Fosså, SD; Horwich, A; Kaiser, G; Koriakine, O; Paluchowska, B; van Oosterom, AT | 1 |
Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
Atil, H; Aysan, T; Cok, G; Göksel, T; Güzelant, A; Soyer, S | 1 |
Lurain, JR; Schink, JC; Singh, DK | 1 |
Cagayan, MS; Lu-Lasala, LR | 1 |
Fujita, H; Kurata, M; Maeda, A; Matsushita, A; Mori, M; Nagai, K; Nagai, Y; Takahashi, T; Tanaka, K; Tanaka, Y; Togami, K | 1 |
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Budnick, A; Deluca, J; Ishill, N; Kondagunta, GV; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J | 1 |
Baishnab, E; Caplin, ME; Standish, RA; Toumpanakis, C; Winslet, MC | 1 |
Bacik, J; Bajorin, DF; Bosl, GJ; Einhorn, L; Lara, PN; Margolin, KA; Mazumdar, M; Motzer, RJ; Nichols, CJ; Richardson, PG; Vogelzang, NJ | 1 |
Biron, P; Bouzy, J; Bui, NB; Caty, A; Chevreau, C; Culine, S; Delva, R; Droz, JP; Fizazi, K; Geoffrois, L; Kerbrat, P; Kramar, A; Pény, J; Théodore, C | 1 |
Culine, S | 1 |
Fizazi, K; Loriot, Y | 1 |
Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ | 1 |
Chan, JK; Chan, WK; Epstein, RJ; Leong, CH; Liang, RH; Yau, T | 1 |
Hasumi, H; Izumi, K; Kanno, H; Mikata, K; Nagashima, Y; Osada, Y; Otai, J; Tsuchiya, F; Umemoto, S | 1 |
Aragane, K; Furukawa, M; Horimoto, M; Hoshino, S; Kawase, I; Kijima, T; Minami, M; Okumura, M; Shiono, H; Suzuki, K | 1 |
Fujisawa, M; Hara, I; Kumano, M; Miyake, H; Muramaki, M; Takenaka, A | 1 |
Bosl, GJ; Feldman, DR; Ishill, N; Jathavedam, A; Motzer, RJ; Patil, S; Turkula, S; Weinstock, DM | 1 |
Caldwell, RD; Case, LD; Harding, RW; Hopkins, JO; Jackson, DV; Muss, HB; Richards, F; Slatkoff, ML; White, DR; Zekan, PJ | 1 |
Huberman, MS; Lokich, JJ; Matelski, HW; Paul, S; Philips, D; Sonneborn, H; Zipoli, TE | 1 |
Rubery, ED | 1 |
Barrett, A; Calvo, F; Hodson, N; Peckham, MJ | 1 |
Kelsen, D | 1 |
Bukowski, RM; Hewlett, JS; Livingston, RB; Montie, J; Mortimer, J | 1 |
Johnson, PJ; Melia, WM; Williams, R | 1 |
Dombernowsky, P; Hansen, HH; Hansen, M; Hirsch, FR; Osterlind, K; Rørth, M; Sörenson, S | 1 |
Edmundson, JM; Shiu, W; Steward, WP; Thatcher, N; Wilkinson, PM | 1 |
Creech, RH; Day, R; Ruckdeschel, JC; Stolbach, LL; Weissman, CH | 1 |
Chahinian, AP; Green, G; Holland, JF | 1 |
de Vries, EG; Meinesz, AF; Mulder, NH; Postmus, PE; Sleijfer, DT; Vriesendorp, R | 1 |
Cirera, L; Doncel, F; Estapé, J; Millá, A | 1 |
D'Incalci, M; Erba, E; Morasca, L; Vaghi, M | 1 |
Alburquerque Carbuccia, H; Madrigal Alonso, P; Perez Manga, G | 1 |
Esparza, L; Hortobagyi, GN; Issell, B; Schell, FC; Yap, HY | 1 |
Balmanno, K; Chapman, F; Charlton, CJ; Gumbrell, L; Lind, MJ; Matthews, JP; Millward, MJ; Newell, DR; Proctor, M; Yuen, K | 1 |
Chiang, Y; Cowan, KH; Dunbar, CE; Goldspiel, B; Kohler, D; McDonagh, KT; Nienhuis, AW; O'Shaughnessy, JA; Sorrentino, BP; Wilson, W | 1 |
Budinsky, A; Eibl, MM; Kaider, A; Krainer, M; Kratzik, C; Michl, I; Wiltschke, C; Wolf, H; Zielinski, CC | 1 |
Bajorin, DF; Bosl, GJ; Motzer, RJ | 1 |
Figurin, KM; Garin, AM; Patiutko, IuI; Polotskiĭ, BE; Sokolov, AV; Tiuliandin, SA | 1 |
Green, MR; Lilenbaum, RC; MacManus, DA | 1 |
Bourhis, JH; Droz, JP; Fadel, E; Ibrahim, A; Pico, JL | 1 |
Cascinu, S; Catalano, G | 1 |
Aledo, A; Boland, P; Casper, ES; Gerald, WL; Healey, JH; Heller, G; Kushner, BH; La Quaglia, MP; Meyers, PA; Wollner, N | 1 |
Elfenbein, GJ; Fields, KK; Perkins, JB | 1 |
Broun, ER; Cornetta, K; Einhorn, LH; Hanna, M; Hromas, R; Kneebone, PH; Loesch, D; Sledge, GW; Sridhara, R | 1 |
Bontenbal, M; de Wit, R; Klijn, JG; Kruit, WH; Planting, AS; Stoter, G; Verweij, J | 1 |
Bontenbal, M; Kok, TC; Planting, AS; Splinter, TA; van der Gaast, A | 1 |
Adenis, A | 1 |
Hammond, CB; Olt, GJ | 1 |
Ballestrero, A; Basta, P; Brema, F; Ferrando, F; Ghio, R; Gobbi, M; Moraglio, L; Patrone, F; Sessarego, M; Valbonesi, M | 1 |
Biakhov, MIu; Buianov, SS; Dobrovol'skaia, NIu; Voznyĭ, EK | 1 |
Slee, PH; Voskuil, JH; Wagenaar, SS | 1 |
de Boer-Dennert, M; Planting, AS; Stoter, G; van der Burg, ME; Verweij, J | 1 |
André, T; Bonnak, H; Bouleuc, C; Donsimoni, R; Esteso, A; Firmin, C; Gerota, J; Izrael, V; Lotz, JP; Merad, Z | 1 |
Brambilla, E; Clavier, J; Gouva, S; Le Reste, N; Leroy, JP; Robinet, G | 1 |
Acimovic, L; Djuric, L; Jeremic, B; Shibamoto, Y | 1 |
Iigo, M; Moriyama, M; Tsuda, H | 1 |
Meisenberg, B | 1 |
Higashida, T; Koishi, Y; Koyama, H; Masuyama, M; Miyata, K; Mugitani, T; Takeuchi, K; Tanaka, H; Taniguchi, H; Yamaguchi, T | 1 |
Kvols, LK | 1 |
Desiderio, F; Fattori, PP; Gianni, L; Nicolini, M; Oliverio, G; Pasquini, E; Ravaioli, A; Scarpellini, M; Tononi, A | 1 |
Broniek, A; Polowiec, Z; Rowinska-Zakrzewska, E; Wiatr, E; Zych, J | 1 |
Arriagada, R; Chomy, P; de Cremoux, H; Le Chevalier, T; Ruffié, P | 1 |
Cottler-Fox, M; Cowan, K; Dunbar, CE; Goodman, S; Leitman, S; Nienhuis, AW; O'Shaughnessy, J; Quesenberry, P; Sorrentino, BP; Stewart, FM | 1 |
Berdel, W; Bokemeyer, C; Clemm, C; Harstrick, A; Hohnloser, J; Illiger, HJ; Metzner, B; Räth, U; Schmoll, HJ; Siegert, W | 1 |
Buzdar, AU; Dicke, KA; Dunphy, FR; Fornoff, JE; Hortobagyi, GN; Huan, SD; Spitzer, G; Yau, JC | 1 |
Adrover, E; Azagra, P; Casado, A; García-Conde, J; Lluch, A; López-Martín, JA; Martín, M; Rodriguez-Lescure, A; Santabárbara, P; Valverde, JJ | 1 |
Kietlińska, Z; Sablińska, B; Zieliński, J | 1 |
Boor, R; Gutjahr, P; Huber, A | 1 |
Ballester, OF; Elfenbein, GJ; Fields, KK; Foody, MC; Hiemenz, JW; Janssen, WE; Kronish, LE; Perkins, JB; Zorsky, PE | 1 |
Calvert, AH; Cantwell, BM; Chapman, F; Charlton, C; Gumbrell, L; Lind, MJ; Millward, MM; Proctor, M; Robinson, A; Simmons, D | 1 |
Adrover, E; Casado, A; Diaz-Rubio, E; García-Conde, J; Lluch, A; Martín, M | 1 |
Abbruzzese, JL; Ajani, JA; Daugherty, K; Markowitz, AB; Patt, YZ | 1 |
Brummett, RE; Dahlborg, SA; Dana, BW; Henner, WD; Neuwelt, EA; Roman-Goldstein, S; Tableman, M; Williams, PC | 1 |
Baki, M; Bodrogi, I; Eckhardt, S; Géczi, L; Hindy, I; Horti, J; Liszka, G; Ottó, S; Sugár, J | 1 |
Elfenbein, GJ; Fields, KK; Moscinski, LC; Perkins, JB | 1 |
Christiansen, NP; Davis, MP; Fay, JW; Herzig, GP; Herzig, RH; Lynch, J | 1 |
Boneu, A; Hartmann, O; Hattchouel, JM; Lumbroso, J; Robert, A; Rodary, C; Rubie, H; Suc, A | 1 |
Blume, KG; Chao, NJ; Hoyle, CF; Kusnierz-Glaz, CR; Long, GD; Negrin, RS; Schriber, JR | 1 |
de Boer-Dennert, M; Planting, AS; Stoter, G; van den Bent, MJ; van der Burg, ME; Verweij, J | 1 |
Biron, P; Droz, JP | 1 |
Berkowitz, I; Cirrincione, C; Clamon, G; Green, MR; Herndon, JE; Muscato, JJ; Omura, G; Perry, MC; Reid, T | 1 |
Fujishiro, Y; Fuse, H; Katayama, T; Muraishi, Y | 1 |
Altman, DG; Blandy, JP; Oliver, RT; Ong, J | 1 |
Bosnjak, SM; Mitrović, LB; Nesković-Konstantinović, ZB; Radulović, SS | 1 |
Clemm, C; Gerl, A; Hentrich, M; Lamerz, R; Schmeller, N; Wilmanns, W | 1 |
Brugger, W; Engelhardt, R; Fetscher, S; Frommhold, H; Hasse, J; Kanz, L; Lange, W; Mertelsmann, R; Wenger, M | 1 |
Arese, P; Camanni, M; Deltetto, F; Durando, A; Massobrio, M; Pesola, D; Sberveglieri, M | 1 |
Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, P; Liippo, K; Manegold, C; Mattson, K; Ricci, S; Sederholm, C; Stahel, P; ten Bokkel Huinink, W; van Walree, N; von Pawel, J; Wagenius, G | 1 |
Begent, RH; Bower, M; Holden, L; Newlands, ES; Rustin, GJ | 1 |
Carpenter, PA; Lockwood, L; McCowage, GB; Nayanar, V; Shaw, PJ; Tiedemann, K; Toogood, I; White, L | 1 |
Bergman, B; Chemaissani, A; Dornoff, W; Drings, P; Kellokumpu-Lehtinen, P; Liippo, K; Manegold, C; Mattson, K; Ricci, S; Sederholm, C; Stahel, RA; ten Bokkel-Huinink, W; van Pawel, J; van Walree, N; Wagenius, G | 1 |
Beuzeboc, P; Diéras, V; Dorval, T; Garcia-Giralt, E; Jouve, M; Palangié, T; Pierga, JY; Pouillart, P; Scholl, SM | 1 |
Goldberg, SL; Klumpp, TR; Magdalinski, AJ; Mangan, KF | 1 |
Evans, TR; Gogas, H; Lofts, FJ; Mansi, JL; Millard, FJ; Wilson, R | 1 |
Buhles, W; Hersh, E; Issell, B; Neidhart, J; Rinehart, J; Triozzi, P | 1 |
Ando, M; Eguchi, K; Hojo, N; Kakinuma, R; Kasai, T; Kodama, T; Kubota, K; Kurata, T; Matsumoto, T; Nishiwaki, Y; Ohe, Y; Ohmatsu, H; Saijo, N; Sekine, I; Shinkai, T; Tamura, T; Yamamoto, N | 1 |
Bilkay, BC; Burgut, R; Erkisi, M; Hazar, B; Seyrek, E | 1 |
Buckley, J; Cairo, M; Feig, S; Harris, RE; Matthay, K; Ozkaynak, MF; Reynolds, CP; Seeger, RC; Villablanca, JG | 1 |
Baker, WJ; Burrell, LM; Lee, N; Perry, JJ; Vukelja, SJ | 1 |
Hortobagyi, GN; Pusztai, L; Theriault, RL; Valero, V; Walters, RS | 1 |
Matsushima, K; Mukaida, N; Nishioka, Y; Nokihara, H; Sone, S; Tsuruo, T; Yano, S | 1 |
Debruyne, FM; Witjes, JA | 1 |
Borsellino, N; Colucci, G; Fortunato, S; Gebbia, N; Gebbia, V; Giuliani, F; Lelli, G; Lopez, M; Maiello, E; Testa, A | 1 |
Fleming, DR; Goldsmith, GC; Herzig, RH; Stevens, DA | 1 |
Beyer, J; Bokemeyer, C; Einhorn, L; Harstrick, A; Hartmann, JT; Kanz, L; Kollmannsberger, C; Meisner, C; Metzner, B; Nichols, C; Schmoll, HJ | 1 |
Bosquée, L; Humblet, Y; Lange, A; Leyvraz, S; Marangolo, M; Pampallona, S; Pasini, F; Perey, L; Peters, R; Rosti, G | 1 |
Fossella, FV; Fox, NJ; Glisson, BS; Hong, WK; Kurie, JM; Lee, JS; Murphy, WK; Nyberg, DA; Perez-Soler, R; Pisters, KM; Ross, MB; Shin, DM | 1 |
Albers, P; Bierhoff, E; deRiese, W; Hartmann, M; Kuczyk, M; Loy, V; Rebmann, U; Schulze, H; Siener, R; Weinknecht, S; Wittekind, C | 1 |
Asbury, R; Boros, L; Chang, AY; Garrow, G; Hui, L; Rubins, J | 1 |
Fried, G; Haim, N; Stein, ME | 1 |
Conrad, EU; Felgenhauer, J; Hawkins, D; Lindsley, K; Miser, JS; Pendergrass, T | 1 |
Atassi, G; Guilbaud, N; Jan, M; Kraus-Berthier, L; Naze, M; Pierré, A | 1 |
Plummer, ER; Roberts, JT | 1 |
Bilgrami, S; Bona, RD; Clive, J; Edwards, RL; Feingold, JM; Kazierad, D; Khan, AM; Khan, IA; Rodriguez-Pinero, F; Tutschka, PJ | 1 |
Appella, E; Connell, T; Gao, C; Moul, JW; Nagaich, AK; Saito, S; Seth, P; Srivastava, S; Zou, Z | 1 |
Bandyopadhyay, S; Goodarzi, G; Gross, SC; Mashimo, T; Pai, SK; Watabe, K; Watabe, M | 1 |
Olver, IN; Schulze, D; Stephenson, J | 1 |
Cullen, MH; Dearnaley, DP; Fossa, SD; Harland, SJ; Horwich, A; Lallemand, E; Mead, GM; Oliver, RT; Roberts, JT; Stenning, SP; Wilkinson, PM | 1 |
Dempke, W; Kellner, O; Schmoll, HJ; von Poblozki, A; Wolf, HH | 1 |
Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
Boyer, MJ; Clarke, SJ; Davis, I; Goldstein, D; Millward, MJ; Mitchell, P; Olver, IN; Richardson, G | 1 |
Asterling, S; LeVay, JH; McLaren, B; Murray, P; Oliver, RT; Ong, J; Shamash, J | 1 |
Baltaci, S; Bedük, Y; Orhan, D; Tulunay, O; Türkölmez, K; Yesilli, C | 1 |
Bode, U; Fleischhack, G; Hasan, C; Hettmer, S; Jaehde, U; Reif, S | 1 |
Baker, DL; Chan, KW; Davis, JH; Dickman, PS; Gerbing, RB; Gorlick, RG; Grovas, A; Herzog, CE; Krailo, MD; Ladanyi, M; Lindsley, KL; Liu-Mares, W; Meyers, PA; Nachman, JB; Sailer, SL; Sieger, L; Wadman, J | 1 |
Altintaş, A; Vardar, MA | 1 |
Fukuda, M; Horibe, K; Inaba, J; Kondo, M; Matsumoto, K; Miyajima, Y; Miyashita, Y | 1 |
Hanibuchi, M; Higasida, T; Nishioka, Y; Nokihara, H; Sone, S; Tsuruo, T; Yano, S | 1 |
Böhmer, S; Goeschen, K; Gurlit, L; Hartlapp, HJ; Krech, R; Lampe, S | 1 |
Eriksson, B; Fjällskog, ML; Granberg, D; Grimfjärd, P; Oberg, K; Skogseid, B; Wilander, E | 1 |
Fischer, L; Foss, HD; Koch, HC; Korfel, A; Thiel, E | 1 |
Bernstein, M; Devidas, M; Ferguson, W; Gebhardt, MC; Goorin, AM; Grier, HE; Harris, MB; Link, M; Schwartz, CL; Siegal, GP | 1 |
Breitfeld, PP; Crist, WM; Donaldson, SS; Lobe, T; Lyden, E; Maurer, HM; Raney, RB; Ruymann, FB; Teot, LA; Wharam, M | 1 |
Martín, M | 1 |
Einhorn, LH | 1 |
Abraham, J; Alexander, R; Bakke, S; Bartlett, D; Bates, S; Choyke, P; Fojo, T; Hung, E; Meadows, B; Merino, M; Robey, R; Rutt, A; Schrump, D; Steinberg, SM | 1 |
Barlogie, B; Corry, PM; Dosik, G; Freireich, EJ; Hankenson, R; Johnston, DA; Khalil, K; Lawson, R; Lippman, L; Reilly, E; Rigor, B; Tenczynski, TF; Yip, E | 1 |
Hartmann, D; Obrecht, JP; Stalder, GA | 1 |
Bauer, M; Bennett, JM; Creech, R; Hahn, RG; Wampler, G; Wolter, J | 1 |
Creagan, ET; Eagan, RT; Fleming, TR; Frytak, S; Ingle, JN; Kvols, LK; Rubin, J | 1 |
Brunner, KW; Cavalli, F; Hasler, E; Martin, J; Ryssel, HJ; Sonntag, RW; Tschopp, L | 1 |
Barouh, M; Carpentier, Y; Cattan, A; Cattan, E; Pourny, C | 2 |
Ahmann, DL; Bisel, HF; Eagan, RT | 1 |
Ansari, R; Einhorn, L; Loehrer, PJ; Pennington, K; Rynard, S; Songer, J | 1 |
Ahlgren, JD; Schulof, RS; Wampler, GL | 1 |
Fujita, J; Fujita, T; Irino, S; Kubo, A; Morikawa, N; Shiotani, T; Takahara, J; Takigawa, K; Yamagishi, Y; Yamaji, Y | 1 |
Greco, FA; Hainsworth, JD; Hande, KR; Johnson, DH; Murphy, PB | 1 |
Furuse, K | 1 |
Ezaki, K; Hirano, M; Ino, T; Maruyama, F; Matsui, T; Miyazaki, H; Okamoto, M; Shimizu, K; Shinkai, K; Sobue, R | 1 |
Gedikoğlu, G; Zülfikar, B | 1 |
Bokemeyer, C; Harstrick, A; Knipp, H; Köhne-Wömpner, CH; Meyer, HJ; Preusser, P; Schmoll, HJ; Stahl, M; Wilke, H | 1 |
Ariad, S; Bezwoda, WR; Seymour, L | 1 |
Cold, S; Pfeiffer, P; Rose, C | 1 |
Burt, P; Prendiville, J; Radford, J; Ranson, M; Steward, W; Stout, R; Thatcher, N | 1 |
Lakomek, M; Schröter, W; Walka, MM | 1 |
Colbeck, RA; Crawford, SM; Williams, G | 1 |
Bliss, JM; Hogan, SJ; Horwich, A; Price, P | 1 |
Carlson, RW; Dorfman, RF; Sikic, BI | 1 |
Ayass, M; Gross, S; Harper, J | 1 |
Childers, JM; Surwit, EA | 1 |
Dawson, N; Perry, J; Redmond, J; Sowray, P; Vukelja, SJ | 1 |
Albertini, M; Saphner, T; Tormey, DC | 1 |
Buzdar, A; Dunphy, F; Ewer, M; Holmes, F; Hortobagyi, G; Huan, S; Spitzer, G; Theriault, R; Wallerstein, R; Yau, J | 1 |
Abratt, RP; Bolding, E; Hewitson, RH; Willcox, PA | 1 |
Blancy, E; Bugat, R; Canal, P; Chatelut, E; Chevreau, C; Houin, G; Lequellec, A; Roche, H | 1 |
Eiermann, W; Fateh-Moghadam, A; Hepp, H; Meier, W; Schneider, A; Stieber, P | 1 |
Kondoh, I; Moriyama, M; Murai, T | 1 |
Ellison, NM; Kardinal, CG; Krook, JE; Loprinzi, CL; Mailliard, JA; Nelimark, RA; Pfeifle, DM; Reuter, NF; Schaid, DJ | 1 |
Muggia, FM | 1 |
Milani, A; Pasi, M; Piva, L; Pizzocaro, G; Salvioni, R; Zanoni, F | 1 |
Bielat, K; Castillo, NB; Lele, SB; Patsner, B; Piver, MS; Tsukada, Y | 1 |
Evans, WK; Osoba, D; Rusthoven, JJ; Shepherd, FA; Turnbull, KA | 1 |
Clark, S; Donohue, JP; Einhorn, LH; Hui, S; Loehrer, PJ; Mandelbaum, I; Rowland, R; Seal, M; Ulbright, T; Williams, SD | 1 |
Eeles, R; Peckham, MJ; Tait, DM | 1 |
Horwich, A; Peckham, MJ | 1 |
Goldstraw, P; Husband, JE; Tait, DM | 1 |
Finkel, HE; Griffing, GT; Hesketh, PJ; Larmon, SS; McCaffrey, RP; Melby, JC | 1 |
Atlas, SA; Bosl, GJ; Leitner, SP; Preibisz, JJ; Scheiner, E; Sealey, JE | 1 |
Dawson, NA; Knight, RD; McLeod, DG; Perry, DJ; Skoog, SJ; Taylor, G | 1 |
Boven, E; De Pauw, M; Harris, A; Jones, W; Kaye, SB; Sleijfer, D; Splinter, T; Stoter, G; Ten Bokkel Huinink, W; Van Oosterom, A | 1 |
Cellerino, R; Menichetti, ET; Miseria, S; Silva, RR; Torresi, U; Tummarello, D | 1 |
Christiansen, NP; Kennedy, BJ | 1 |
Burton, GV; Cox, EB; Olsen, GA; Vugrin, D | 1 |
Chiuten, DF; Dhingra, HM; Holoye, PY; Jeffries, D; Lee, JS; Murphy, WK; Neidhart, JA; Umsawasdi, T | 1 |
Ballatori, E; Buzzi, F; Corgna, E; Crinó, L; Darwish, S; Di Costanzo, F; Fornari, G; Luccioli, L; Meacci, ML; Santi, F | 1 |
Anderson, N; Bern, M; Lokich, J; Moore, C; Wallach, S; Williams, D | 1 |
Greco, FA; Grosh, WW; Hainsworth, JD; Hande, KR; Johnson, DH; Porter, LL; Wolff, SN | 1 |
Finkel, H; Grapski, RT; Krikorian, JG; Lopez, JA; Mann, J; Nassif, E; Vannicola, P | 1 |
Kobayashi, O; Matsui, H; Sekiya, S; Takamizawa, H | 1 |
Buzdar, AU; Fraschini, G; Holmes, FA; Hortobagyi, GN; Hug, V; Jabboury, K; Kau, SW; Theriault, RL | 1 |
Arnold, H; Dölken, G; Hecht, T; Sommerkamp, H; Thriemer, M; Wannenmacher, M | 1 |
Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S | 1 |
Athanassiades, P; Bacoyiannes, H; Kontoyiannes, D | 1 |
Beltangady, M; Crist, WM; Heyn, R; Johnston, J; Ragab, A; Raney, RB; Webber, B; Wharam, M | 1 |
Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC | 1 |
Greco, FA; Johnson, DH | 1 |
Buckner, J; Einzig, A; Heelan, R; Kelsen, DP; Magill, G; Vinciguerra, V | 1 |
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S | 1 |
19 review(s) available for etoposide and Neoplasm Metastasis
Article | Year |
---|---|
Current concepts in the management of small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Platinum; Randomized Controlled Trials as Topic; Recurrence; Small Cell Lung Carcinoma; Treatment Outcome | 2013 |
[Chemotherapy in male external genital organs (testicular and penile cancer)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Cryopreservation; Etoposide; Fluorouracil; Humans; Ifosfamide; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Paclitaxel; Penile Neoplasms; Spermatozoa; Testicular Neoplasms; Vinblastine | 2013 |
[Small cell neuroendocrine carcinoma of the uterine cervix: Report of six cases and a review of the literature].
Topics: Adult; Antineoplastic Agents; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymph Node Excision; Middle Aged; Neoplasm Metastasis; Radiotherapy, Adjuvant; Retrospective Studies; Uterine Cervical Neoplasms | 2014 |
Primary Yolk Sac Tumor of the Prostate: A Case Report and Review of the Literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Endodermal Sinus Tumor; Etoposide; Humans; Male; Neoplasm Metastasis; Prostatectomy; Prostatic Neoplasms; Recurrence; Robotic Surgical Procedures; Testicular Neoplasms; Treatment Outcome; Vincristine | 2015 |
An update on chemotherapy for osteosarcoma.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Doxorubicin; Etoposide; Humans; Ifosfamide; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Randomized Controlled Trials as Topic | 2015 |
Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Salvage Therapy; Testicular Neoplasms | 2010 |
Testis conserving chemotherapy in germ cell cancer: its potential to increase understanding of the biology and treatment of carcinoma-in-situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Orchiectomy; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 2003 |
[Management of localized germ-cell tumours of the testis].
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Clinical Protocols; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Etoposide; Follow-Up Studies; Humans; Lymph Node Excision; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Practice Guidelines as Topic; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Seminoma; Testicular Neoplasms; Testis; Time; Time Factors | 2007 |
Chemotherapy of esophageal cancer.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine | 1984 |
High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 1995 |
Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Topics: Biomarkers, Tumor; Carcinoid Heart Disease; Carcinoid Tumor; Cisplatin; Combined Modality Therapy; Cyproheptadine; Echocardiography; Etoposide; Humans; Interferon Type I; Magnetic Resonance Imaging; Malignant Carcinoid Syndrome; Neoplasm Metastasis; Receptors, Somatostatin; Recombinant Proteins | 1994 |
High dose versus standard dose chemotherapy for the treatment of breast cancer. A review of current concepts.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Busulfan; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Paclitaxel; Taxoids; Thiotepa | 1995 |
Late relapse of germ cell tumors after cisplatin-based chemotherapy.
Topics: Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoma, Embryonal; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Fatal Outcome; Germinoma; Humans; Life Tables; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Orchiectomy; Pelvic Neoplasms; Remission Induction; Retroperitoneal Neoplasms; Retrospective Studies; Salvage Therapy; Teratocarcinoma; Testicular Neoplasms; Treatment Failure | 1997 |
[Chemotherapy of testicular cancer].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Protocols; Disease-Free Survival; Etoposide; Germinoma; Humans; Incidence; Male; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Testicular Neoplasms; Vinblastine | 1999 |
Metastatic adult medulloblastoma showing prolonged response to chemotherapy.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Combined Modality Therapy; Etoposide; Humans; Male; Medulloblastoma; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors; Vincristine | 1999 |
Platinum compounds in the treatment of advanced breast cancer.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Mastectomy; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Preoperative Care; Severity of Illness Index; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Remission Induction; Thymus Neoplasms; Vinblastine | 1990 |
[Current status of the therapy of malignant testicular tumors].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Cisplatin; Combined Modality Therapy; Dysgerminoma; Etoposide; Humans; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Metastasis; Orchiectomy; Prognosis; Radiotherapy Dosage; Teratoma; Testicular Neoplasms; Vinblastine | 1988 |
117 trial(s) available for etoposide and Neoplasm Metastasis
Article | Year |
---|---|
FOLFIRINEC: a randomized phase II trial of mFOLFIRINOX vs platinum-etoposide for metastatic neuroendocrine carcinoma of gastroenteropancreatic or unknown origin.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Carcinoma, Neuroendocrine; Etoposide; Female; Fluorouracil; Humans; Intestinal Neoplasms; Irinotecan; Leucovorin; Male; Neoplasm Metastasis; Neoplasms, Unknown Primary; Neuroendocrine Tumors; Oxaliplatin; Pancreatic Neoplasms; Platinum Compounds; Progression-Free Survival; Prospective Studies; Quality of Life; Stomach Neoplasms; Survival Rate; Treatment Outcome | 2021 |
A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Etoposide; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Retrospective Studies; Tomography, X-Ray Computed; Young Adult | 2017 |
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Decision Trees; Disease Management; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2017 |
A Phase II Study of Irinotecan and Etoposide as Treatment for Refractory Metastatic Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Etoposide; Female; Humans; Irinotecan; Middle Aged; Neoplasm Metastasis; Topoisomerase I Inhibitors | 2019 |
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Etoposide; Humans; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Palliative Care; Prednisone; Prostatic Neoplasms, Castration-Resistant; Taxoids; Vinblastine; Vinorelbine | 2015 |
Prognostic factors and efficacy of different chemotherapeutic regimens in patients with mediastinal nonseminomatous germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Testicular Neoplasms; Vincristine; Young Adult | 2014 |
Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Comorbidity; Etoposide; Female; Humans; Indoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pyrroles; Small Cell Lung Carcinoma; Treatment Outcome | 2014 |
Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Grading; Neoplasm Metastasis; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Treatment Outcome | 2014 |
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; International Agencies; Lenograstim; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peritoneal Neoplasms; Precision Medicine; Prognosis; Recombinant Proteins; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
Comparative outcome of Thai pediatric osteosarcoma treated with two protocols: the role of high-dose methotrexate (HDMTX) in a single institute experience.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Extremities; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Staging; Osteosarcoma; Prognosis; Retrospective Studies; Survival Rate | 2014 |
Chemotherapy: The role of ifosfamide and etoposide in Ewing sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Neoplasm Metastasis; Radiography; Sarcoma, Ewing; Time Factors; Treatment Outcome; Tumor Burden; Vincristine | 2009 |
Phase 2 trial of two courses of cyclophosphamide and etoposide for relapsed high-risk osteosarcoma patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Osteosarcoma | 2009 |
"Metronomic" chemotherapy in advanced soft tissue sarcomas.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Sarcoma; Treatment Outcome | 2010 |
A multicenter international randomized phase III study comparing cisplatin in combination with irinotecan or etoposide in previously untreated small-cell lung cancer patients with extensive disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Etoposide; Female; Humans; International Agencies; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Prognosis; Small Cell Lung Carcinoma; Survival Rate; Young Adult | 2010 |
Phase II trial to evaluate gemcitabine and etoposide for locally advanced or metastatic pancreatic cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pancreatic Neoplasms; Survival Analysis | 2010 |
A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis germ-cell cancer. An intergroup study of EORTC, GTCSG, and Grupo Germinal (EO
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Stem Cell Transplantation; Testicular Neoplasms; Young Adult | 2011 |
Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Recurrence; RNA-Binding Protein EWS; Sarcoma, Ewing; Survival Rate; Vincristine | 2011 |
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Differentiation; Chromogranin A; Disease-Free Survival; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Neuroendocrine Cells; Orchiectomy; Prospective Studies; Prostatic Neoplasms | 2011 |
Population-based study of treatment guided by tumor marker decline in patients with metastatic nonseminomatous germ cell tumor: a report from the Swedish-Norwegian Testicular Cancer Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Norway; Population Surveillance; Prognosis; Sweden; Testicular Neoplasms | 2011 |
Successful treatment of metastatic retinoblastoma with high-dose chemotherapy and autologous stem cell rescue in South America.
Topics: Antineoplastic Agents; Carboplatin; Child, Preschool; Etoposide; Female; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Retinoblastoma; South America; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2012 |
Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prognosis; Proportional Hazards Models; Treatment Outcome | 2011 |
Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma.
Topics: Administration, Metronomic; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Salvage Therapy; Treatment Outcome | 2013 |
Radiotherapy alone versus radiochemotherapy in patients with stage IIIA adenocarcinoma (ADC) of the lung.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Chemoradiotherapy; Disease Progression; Disease-Free Survival; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Prospective Studies; Radiotherapy; Time Factors | 2013 |
Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Etoposide; Female; Fluorouracil; Hepatoblastoma; Humans; Infant; Infant, Newborn; Liver Neoplasms; Male; Neoplasm Metastasis; Survival Rate; Vincristine | 2002 |
Phase I/II trial of weekly cisplatin, etoposide, and irinotecan chemotherapy for metastatic lung cancer: JCOG 9507.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Irinotecan; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Survival; Thrombocytopenia | 2003 |
Infusional fluorouracil, etoposide, and cisplatin (FEP) in advanced and relapsed gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Stomach Neoplasms; Survival Analysis | 2003 |
Cisplatin plus etoposide in advanced non-small cell lung cancer patients age of 70 years or older.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Health Services for the Aged; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Treatment Outcome | 2003 |
Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Sarcoma, Ewing; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Seminoma; Testicular Neoplasms; Treatment Outcome | 2004 |
Phase II trial of estramustine and etoposide in androgen-sensitive metastatic prostate carcinoma.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Estramustine; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Survival Rate | 2004 |
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Neuroblastoma; Neutropenia; Radiopharmaceuticals; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Quality of Life | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Disease-Free Survival; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Recurrence, Local; Treatment Outcome | 2005 |
Intensive induction chemotherapy with C-BOP/BEP for intermediate- and poor-risk metastatic germ cell tumours (EORTC trial 30948).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Ovarian Neoplasms; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Vincristine | 2005 |
Paclitaxel plus Ifosfamide followed by high-dose carboplatin plus etoposide in previously treated germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Disease-Free Survival; Etoposide; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Stem Cell Transplantation; Treatment Outcome | 2007 |
Phase III randomized trial of conventional-dose chemotherapy with or without high-dose chemotherapy and autologous hematopoietic stem-cell rescue as first-line treatment for patients with poor-prognosis metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carboplatin; Cisplatin; Disease Progression; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Survival Analysis; Treatment Outcome | 2007 |
Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Risk Factors; Survival Analysis; Testicular Neoplasms; Time Factors; Treatment Outcome | 2007 |
CMED in the treatment of nasal natural killer cell lymphoma with distant metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Etoposide; Female; Humans; Killer Cells, Natural; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Nose Neoplasms; Radiotherapy, Adjuvant; Salvage Therapy; Survival Analysis; Treatment Outcome | 2007 |
VP-16-213 in combination chemotherapy with chest irradiation for small-cell lung cancer: a randomized trial of the Piedmont Oncology Association.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Vincristine | 1984 |
Induction of remission in hepatocellular carcinoma. A comparison of VP 16 with adriamycin.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Doxorubicin; Etoposide; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Prognosis; Random Allocation | 1983 |
Continuous versus alternating combination chemotherapy for advanced small cell carcinoma of the lung.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Etoposide; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Neoplasm Metastasis; Prognosis; Vincristine | 1983 |
Chemotherapy for metastatic non-small cell bronchogenic carcinoma: cyclophosphamide, doxorubicin, and etoposide versus mitomycin and vinblastine (EST 2575, generation IV).
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycins; Neoplasm Metastasis; Vinblastine | 1984 |
Mitomycin-C, etoposide, cisplatin, and hexamethylmelamine (MEPH) as a second-line regimen in lung cancer.
Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Thrombocytopenia; Vomiting | 1984 |
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Marrow; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1995 |
A phase I trial of paclitaxel and etoposide for metastatic or recurrent malignancies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Neutropenia; Paclitaxel; Thrombocytopenia | 1995 |
Escalating dose of tegafur combined with oral etoposide in metastatic gastric carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Tegafur | 1995 |
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Male; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Remission Induction; Risk Factors; Sarcoma, Ewing; Survival Rate; Vincristine | 1995 |
Ifosfamide/carboplatin/etoposide chemotherapy for metastatic breast cancer with or without autologous hematopoietic stem cell transplantation: evaluation of dose-response relationships.
Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis | 1995 |
Tandem autotransplantation for the treatment of metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Diarrhea; Disease-Free Survival; Etoposide; Feasibility Studies; Female; Humans; Middle Aged; Mouth Mucosa; Neoplasm Metastasis; Remission Induction; Stomatitis; Transplantation, Autologous | 1995 |
Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1995 |
Phase II study of carboplatin and etoposide as a first line regimen in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Disease-Free Survival; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Treatment Outcome | 1994 |
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neutropenia; Remission Induction; Thrombocytopenia; Vincristine | 1995 |
Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Remission Induction; Salvage Therapy; Treatment Outcome | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Enterocolitis; Etoposide; Female; Germinoma; Humans; Ifosfamide; Kidney; Male; Middle Aged; Neoplasm Metastasis; Ovarian Neoplasms; Pregnancy; Prognosis; Remission Induction; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Survival Rate; Time Factors | 1995 |
[Recurrence and survival rate of advanced gastric cancer after preoperative EAP-II intra-arterial infusion therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Epirubicin; Etoposide; Humans; Infusions, Intra-Arterial; Neoplasm Metastasis; Neoplasm Recurrence, Local; Preoperative Care; Stomach Neoplasms; Survival Rate | 1994 |
Etoposide, doxorubicin and cisplatin (EAP regimen) in advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms | 1994 |
Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure | 1994 |
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Male; Neoplasm Metastasis; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome | 1993 |
Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support.
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prognosis; Proportional Hazards Models; Receptors, Estrogen; Risk Factors | 1994 |
Clinical activity of chronic oral etoposide in previously treated metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1994 |
Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Immunotherapy; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Stem Cell Transplantation; Survival Analysis; Thiotepa | 1993 |
Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1993 |
Preliminary results of a phase II trial of chronic oral etoposide in breast cancer.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1993 |
Phase II study of etoposide and alpha-interferon in patients with advanced measurable colorectal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Drug Synergism; Etoposide; Female; Humans; Interferon-alpha; Male; Middle Aged; Neoplasm Metastasis | 1993 |
Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carboplatin; Child; Etoposide; Female; Germinoma; Glioblastoma; Humans; Lymphoma; Male; Middle Aged; Neoplasm Metastasis; Neuroectodermal Tumors, Primitive; Oligodendroglioma; Tomography, X-Ray Computed | 1995 |
Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Drug Resistance; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Treatment Failure; Vinblastine | 1994 |
Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis | 1996 |
Etoposide (VP-16) and cisplatin at maximum tolerated dose in non-small cell lung carcinoma: a Cancer and Leukemia Group B study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Survival Rate; Time Factors; Treatment Failure | 1995 |
Daily oral etoposide in metastatic breast cancer.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1996 |
Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Carboplatin; Carcinoma, Small Cell; Cardiovascular Diseases; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pneumonectomy; Remission Induction; Survival Analysis; Transplantation Conditioning; Treatment Outcome | 1997 |
Carboplatin plus etoposide regimen in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Administration Schedule; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Survival Rate; Treatment Outcome | 1997 |
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Drug Administration Schedule; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neoplasm Metastasis; Ribonucleotide Reductases; Treatment Outcome; Vomiting | 1997 |
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/progressive or advanced solid tumors of childhood: a report from the Australia and New Zealand Children's Cancer Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Etoposide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Infant; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms; Survival Analysis; Vincristine | 1997 |
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1997 |
Phase II trial of doxorubicin, 5-fluorouracil, etoposide, and cisplatin in advanced or recurrent endometrial carcinoma.
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Survival Rate | 1997 |
Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival an
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous | 1997 |
Outpatient treatment with epirubicin and oral etoposide in patients with small-cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Epirubicin; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Outpatients; Survival Rate | 1997 |
Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Humans; Interleukin-1; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Neutropenia; Recombinant Proteins; Thrombocytopenia | 1997 |
Phase I study of sequentially administered topoisomerase I inhibitor (irinotecan) and topoisomerase II inhibitor (etoposide) for metastatic non-small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Enzyme Inhibitors; Etoposide; Female; Hematologic Diseases; Humans; Irinotecan; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1997 |
Refractory breast cancer: a comparison of two different chemotherapy regimens.
Topics: Administration, Oral; Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Injections, Intravenous; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Remission Induction; Turkey | 1997 |
Double-alkylator non-total-body irradiation regimen with autologous hematopoietic stem-cell transplantation in pediatric solid tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Melphalan; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Analysis; Transplantation, Autologous | 1998 |
Daily oral etoposide in patients with heavily pretreated metastatic breast cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Salvage Therapy | 1998 |
Epirubicin, folinic acid, fluorouracil, and etoposide in the treatment of advanced gastric cancer: phase II study of the Southern Italy Oncology Group (GOIM).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Stomach Neoplasms; Survival Analysis | 1999 |
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Europe; Feasibility Studies; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Ifosfamide; Logistic Models; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Recombinant Proteins | 1999 |
Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Paclitaxel | 1999 |
Risk factors for relapse in stage I non-seminomatous germ-cell tumors: preliminary results of the German Multicenter Trial. German Testicular Cancer Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Germinoma; Humans; Lymph Node Excision; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Recurrence; Reproducibility of Results; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Testicular Neoplasms; Tomography, X-Ray Computed | 1999 |
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Ifosfamide; Middle Aged; Neoplasm Metastasis; Safety; Salvage Therapy | 1999 |
Clinical activity of cisplatin and prolonged oral administration of etoposide in previously treated, anthracycline-resistant, metastatic breast cancer patients: a phase II study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Middle Aged; Nausea; Neoplasm Metastasis; Nervous System Diseases; Remission Induction; Stomatitis; Time Factors; Treatment Outcome; Vomiting | 2000 |
Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Child, Preschool; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Male; Mesna; Mouth Mucosa; Neoplasm Metastasis; Neutropenia; Prospective Studies; Remission Induction; Sarcoma; Stomatitis; Time Factors; Treatment Outcome; Vincristine | 2000 |
Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Paclitaxel; Remission Induction; Taxoids; Treatment Outcome | 2000 |
A phase I study of prolonged ambulatory infusion carboplatin with oral etoposide showing activity in prostate cancer.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carboplatin; Drug Therapy, Combination; Etoposide; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Pain; Prostatic Neoplasms; Treatment Outcome | 2000 |
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neutropenia; Seminoma; Survival Analysis; Testicular Neoplasms; Thrombocytopenia; Time Factors; Treatment Outcome | 2000 |
Phase II study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer.
Topics: Administration, Oral; Adult; Aged; Carcinoma, Non-Small-Cell Lung; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Survival Analysis; Treatment Outcome | 2001 |
Carboplatin AUC8 in combination with etoposide and bleomycin in the treatment of intermediate and poor-risk metastatic germ cell tumours: a phase II study.
Topics: Adolescent; Adult; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Carboplatin; Etoposide; Female; Germinoma; Humans; Leukocyte Count; Male; Neoplasm Metastasis; Retrospective Studies | 2001 |
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Child; Child, Preschool; Chromatography, High Pressure Liquid; Etoposide; Female; Half-Life; Humans; Injections, Intraventricular; Male; Medulloblastoma; Neoplasm Metastasis | 2001 |
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Disease Progression; Dose-Response Relationship, Drug; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Male; Melphalan; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Transplantation, Autologous; Treatment Outcome; Whole-Body Irradiation | 2001 |
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Infusions, Intravenous; Male; Neoplasm Metastasis; Neutropenia; Osteosarcoma; Thrombocytopenia; Treatment Outcome | 2002 |
Ifosfamide and etoposide are superior to vincristine and melphalan for pediatric metastatic rhabdomyosarcoma when administered with irradiation and combination chemotherapy: a report from the Intergroup Rhabdomyosarcoma Study Group.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bronchiolitis Obliterans; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kidney Diseases; Life Tables; Male; Melphalan; Neoplasm Metastasis; Radiotherapy, Adjuvant; Remission Induction; Rhabdomyosarcoma; Sepsis; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
Phase II study of single-agent therapy with megestrol acetate, VP-16-213, cyclophosphamide, and dianhydrogalactitol in advanced renal cell cancer.
Topics: Adenocarcinoma; Adult; Aged; Clinical Trials as Topic; Cyclophosphamide; Dianhydrogalactitol; Drug Evaluation; Etoposide; Humans; Kidney Neoplasms; Megestrol; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Sugar Alcohols | 1979 |
Evaluation of VP-16 and the combination of adriamycin and vincristine in advanced breast cancer.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1976 |
Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Treatment Outcome | 1992 |
Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Humans; Leukocyte Count; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platelet Count | 1992 |
Platinum/oral etoposide therapy in non-small cell lung cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Etoposide; Female; Hemoglobins; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platelet Count | 1992 |
Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Drug Evaluation; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Remission Induction; Time Factors | 1992 |
High-dose etoposide in treatment of metastatic breast cancer.
Topics: Breast Neoplasms; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Neoplasm Metastasis | 1992 |
Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Remission Induction; Thymus Neoplasms; Vinblastine | 1990 |
High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Methotrexate; Neoplasm Metastasis; Pilot Projects; Pregnancy; Prognosis; Risk Factors; Severity of Illness Index; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1991 |
Continuous infusion 5-fluorouracil with escalating doses of intermittent cisplatin and etoposide. A phase I study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Neoplasms; Stomatitis | 1991 |
Potential advances in combination chemotherapy for advanced testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Podophyllotoxin; Testicular Neoplasms; Vinblastine; Vincristine | 1988 |
Combination chemotherapy with etoposide and 5-fluorouracil in advanced pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pancreatic Neoplasms | 1989 |
Cisplatin and etoposide: an effective treatment for refractory breast carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Drug Administration Schedule; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis | 1989 |
Treatment of advanced non-small cell lung cancer (NSCLC): the "Umbria" cooperative study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Random Allocation | 1988 |
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine | 1986 |
Etoposide (VP-16-213) and cis-dichlorodiammineplatinum (DDP) in advanced breast carcinoma resistant to previous chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Vincristine | 1986 |
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.
Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting | 1985 |
199 other study(ies) available for etoposide and Neoplasm Metastasis
Article | Year |
---|---|
Design, synthesis, biological evaluation and molecular docking study on peptidomimetic analogues of XK469.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Chemistry Techniques, Synthetic; DNA; DNA Topoisomerases, Type II; Drug Design; Humans; Mice; Molecular Docking Simulation; Neoplasm Metastasis; Peptidomimetics; Protein Conformation; Quinoxalines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2016 |
Platinum Doublet plus Atezolizumab as First-line Treatment in Metastatic Large Cell Neuroendocrine Carcinoma: A Single Institution Experience.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Platinum; Prospective Studies; Retrospective Studies; Small Cell Lung Carcinoma; Survival Analysis; Treatment Outcome | 2022 |
Malignant Sex Cord-Stromal Tumor, Not Otherwise Specified, Harboring FOXL2, p53, and TERT Promoter Mutations: Report of a Case.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Female; Forkhead Box Protein L2; Granulosa Cells; Humans; Middle Aged; Mutation; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Promoter Regions, Genetic; Sex Cord-Gonadal Stromal Tumors; Tumor Suppressor Protein p53 | 2020 |
Durable Response to Carboplatin, Etoposide, Nivolumab, and Ipilimumab in Metastatic High-Grade Neuroendocrine Carcinoma of the Gallbladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Etoposide; Female; Gallbladder; Humans; Ipilimumab; Ki-67 Antigen; Middle Aged; Mutation; Neoplasm Grading; Neoplasm Metastasis; Nivolumab; Retinoblastoma Binding Proteins; Treatment Outcome; Tumor Suppressor Protein p53; Ubiquitin-Protein Ligases | 2020 |
Metastatic Malignant Peripheral Nerve Sheath Tumor With NF1 Successfully Treated With 'Gradual Subtraction' ICE Chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Humans; Ifosfamide; Male; Neoplasm Metastasis; Nerve Sheath Neoplasms; Neurofibromatosis 1; Prognosis | 2020 |
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prognosis; Progression-Free Survival; Retroperitoneal Space; Teratoma; Testicular Neoplasms; Young Adult | 2020 |
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
Berberine inhibits chemotherapy-exacerbated ovarian cancer stem cell-like characteristics and metastasis through GLI1.
Topics: Antineoplastic Agents; Berberine; Carboplatin; Cell Line, Tumor; Cell Movement; Coculture Techniques; Epithelial-Mesenchymal Transition; Etoposide; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Metastasis; Neoplastic Stem Cells; Ovarian Neoplasms; Polycomb Repressive Complex 1; Signal Transduction; Snail Family Transcription Factors; Vimentin; Zinc Finger Protein GLI1 | 2021 |
Real-World Study of Cisplatin, Etoposide, and Bleomycin Chemotherapy Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adult; Antineoplastic Agents; Bleomycin; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Male; Middle Aged; Neoplasm Metastasis; Pregnancy; Pregnancy Complications; Prognosis; Prospective Studies; Radiotherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome | 2021 |
Sphingomyelin nanosystems loaded with uroguanylin and etoposide for treating metastatic colorectal cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Delivery Systems; Etoposide; Female; Humans; Mice, Inbred Strains; Mice, Nude; Microscopy, Electron, Scanning; Nanoparticles; Natriuretic Peptides; Neoplasm Metastasis; Particle Size; Receptors, Guanylate Cyclase-Coupled; Sphingomyelins; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |
Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Neuroendocrine; Cell Transformation, Neoplastic; Cisplatin; Cohort Studies; Etoposide; Female; Gastrointestinal Neoplasms; Humans; Male; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis | 2017 |
Long-Term Survival in a Patient With Metastatic DDR2-Positive Adrenal Cortical Carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Carboplatin; Combined Modality Therapy; Discoidin Domain Receptor 2; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Male; Middle Aged; Mitotane; Mutation; Neoplasm Metastasis; Nephrectomy; Tomography Scanners, X-Ray Computed | 2017 |
Report: Small cell neuroendocrine carcinoma (SCNEC) of the tongue: A case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Humans; Male; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Tongue Neoplasms | 2017 |
Paclitaxel as third-line chemotherapy for small cell lung cancer failing both etoposide- and camptothecin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Disease-Free Survival; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Metastasis; Paclitaxel; Retrospective Studies; Small Cell Lung Carcinoma; Treatment Outcome | 2017 |
A rare complication of metastatic lung disease treatment.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Erlotinib Hydrochloride; Etoposide; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Pericardium; Tomography, X-Ray Computed; Tongue Neoplasms | 2017 |
Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Etoposide; Female; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Treatment Outcome | 2018 |
Analysis of the activity and safety of weekly low-dose bevacizumab-based regimens in heavily pretreated patients with metastatic breast cancer.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Etoposide; Female; Humans; Irinotecan; Methotrexate; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pemetrexed; Progression-Free Survival; Treatment Outcome | 2018 |
Treatment of Nonmetastatic Unilateral Retinoblastoma in Children.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Etoposide; Eye Enucleation; Female; Humans; Hydrophthalmos; Idarubicin; Infant; Male; Mesna; Neoplasm Metastasis; Neoplasm Staging; Prospective Studies; Retinal Neoplasms; Retinoblastoma; Survival Rate; Vincristine | 2018 |
Symptomatic hyperthyroidism in metastatic testicular mixed germ cell tumour.
Topics: Adult; Bleomycin; Chemoradiotherapy; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Humans; Hyperthyroidism; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2018 |
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Carcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Chemoembolization, Therapeutic; Cisplatin; Disease Management; Doxorubicin; Endocrinology; Etoposide; Europe; Humans; Mitotane; Neoplasm Metastasis; Prognosis; Radiotherapy; Societies, Medical | 2018 |
Reassessment of 4-Cycle Etoposide and Cisplatin as the Standard of Care for Good-Risk Metastatic Germ Cell Tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choice Behavior; Cisplatin; Dose-Response Relationship, Drug; Etoposide; Guideline Adherence; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Quality of Life; Standard of Care; Survival Rate; Testicular Neoplasms; Treatment Outcome | 2018 |
Solitary Bone Metastasis as the First Presentation of Germ Cell Testicular Cancer Treated with Internal Hemipelvectomy: A Case Report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Neoplasms; Cisplatin; Etoposide; Hemipelvectomy; Humans; Male; Neoplasm Metastasis; Neoplasm, Residual; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Pelvic Bones; Testicular Neoplasms; Treatment Outcome | 2019 |
Oral etoposide for metastatic choriocarcinoma: a case report and review of guidelines.
Topics: Adult; Choriocarcinoma; Etoposide; Female; Humans; Neoplasm Metastasis; Practice Guidelines as Topic; Pregnancy; Uterine Neoplasms | 2019 |
Clinical Prognostic Factors and Outcome in Pediatric Osteosarcoma: Effect of Delay in Local Control and Degree of Necrosis in a Multidisciplinary Setting in Lebanon.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cisplatin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Infant; Lebanon; Male; Methotrexate; Neoadjuvant Therapy; Neoplasm Metastasis; Osteosarcoma; Prognosis; Retrospective Studies; Risk Assessment; Treatment Outcome | 2019 |
Trends in response rate and survival in small-cell lung cancer patients between 1997 and 2017.
Topics: Aged; Bridged-Ring Compounds; Cardiovascular Diseases; Etoposide; Female; France; Humans; Liver Diseases; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Platinum Compounds; Prognosis; Small Cell Lung Carcinoma; Survival Analysis; Taxoids | 2019 |
Case report: Treatment of metastatic germ cell tumor in a newly diagnosed HIV infected man: use of BEP chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; HIV Infections; Humans; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Testicular Neoplasms; Treatment Outcome | 2011 |
Unsuspected metastatic choriocarcinoma presenting as unexplained severe anaemia.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Choriocarcinoma; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Methotrexate; Neoplasm Metastasis; Pregnancy; Uterine Neoplasms; Vincristine | 2013 |
Survival analysis in advanced non small cell lung cancer treated with platinum based chemotherapy in combination with paclitaxel, gemcitabine and etoposide.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Deoxycytidine; Etoposide; Female; Follow-Up Studies; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Prognosis; Retrospective Studies; Survival Rate | 2013 |
Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisplatin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma; Survival Rate; Tumor Burden | 2014 |
Predictors of outcome in patients with advanced nonseminomatous germ cell testicular tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Rate; Testicular Neoplasms; Young Adult | 2014 |
A whole-body dual-modality radionuclide optical strategy for preclinical imaging of metastasis and heterogeneous treatment response in different microenvironments.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; DNA Damage; Environment; Etoposide; Female; Fluorescence; Humans; Lymph Nodes; Microscopy, Confocal; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sodium Pertechnetate Tc 99m; Symporters; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Whole Body Imaging | 2014 |
Treatment of high-risk aggressive B-cell non-Hodgkin lymphomas with rituximab, intensive induction and high-dose consolidation: long-term analysis of the R-MegaCHOP-ESHAP-BEAM Trial.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Consolidation Chemotherapy; Cyclophosphamide; Cytarabine; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Lymphoma, B-Cell; Male; Melphalan; Methylprednisolone; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Podophyllotoxin; Prednisone; Prognosis; Rituximab; Treatment Outcome; Vincristine; Young Adult | 2015 |
Oral cyclophosphamide and etoposide in treatment of malignant pleural mesothelioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2014 |
Efficacy of neo-adjuvant chemotherapy with TEC regimen on breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Middle Aged; Neoadjuvant Therapy; Neoplasm Metastasis; Receptor, ErbB-2; Taxoids; Treatment Outcome | 2015 |
Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.
Topics: Animals; Antineoplastic Agents; Antioxidants; Etoposide; Female; Immunosuppression Therapy; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction | 2015 |
Human Chorionic Gonadotropin (hCG) Regression Curve for Predicting Response to EMA/CO (Etoposide, Methotrexate, Actinomycin D, Cyclophosphamide and Vincristine) Regimen in Gestational Trophoblastic Neoplasia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Nomograms; Pregnancy; Prognosis; Regression Analysis; ROC Curve; Vincristine; Young Adult | 2015 |
Bevacizumab/high-dose chemotherapy with autologous stem-cell transplant for poor-risk relapsed or refractory germ-cell tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Child; Cisplatin; Combined Modality Therapy; Deoxycytidine; Drug Resistance, Neoplasm; Etoposide; Female; Follow-Up Studies; Gemcitabine; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Survival Rate; Testicular Neoplasms; Transplantation, Autologous; Young Adult | 2015 |
Adult Pleomorphic Rhabdomyosarcoma: A Multicentre Retrospective Study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Retrospective Studies; Rhabdomyosarcoma; Survival Rate; Vincristine | 2015 |
Enhanced Anti-Metastatic Activity of Etoposide Using Layered Double Hydroxide Nano Particles.
Topics: Antineoplastic Agents; Biological Transport; Cell Line, Tumor; Cell Movement; Drug Carriers; Drug Liberation; Etoposide; Humans; Hydroxides; Nanoparticles; Neoplasm Invasiveness; Neoplasm Metastasis; Particle Size; Signal Transduction; Up-Regulation | 2015 |
Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Endodermal Sinus Tumor; Etoposide; Hemodiafiltration; Humans; Kidney Diseases; Liver Diseases; Male; Neoplasm Metastasis; Testicular Neoplasms; Tumor Lysis Syndrome; Urate Oxidase | 2016 |
A single-centre analysis of 30 patients with relapsed germ cell tumours treated with the TI-CE regimen.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Prognosis; Prospective Studies; Retrospective Studies; Salvage Therapy; Time Factors; Treatment Outcome; Young Adult | 2016 |
Recurrent 'growing teratoma syndrome' in an adolescent girl with a history of ovarian immature teratoma: A case report.
Topics: Adolescent; Antineoplastic Agents; Biopsy; Cisplatin; Disease Management; Etoposide; Female; Humans; Lymph Nodes; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Second Primary; Omentum; Ovarian Neoplasms; Ovariectomy; Teratoma; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography | 2016 |
A Successfully Treated Metastatic Choriocarcinoma Coexistent With Pregnancy: A Case Report of a 4-Year Follow-Up.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cesarean Section; Choriocarcinoma; Cyclophosphamide; Cytarabine; Etoposide; Female; Humans; Mitoxantrone; Neoplasm Metastasis; Pregnancy; Pregnancy Complications, Neoplastic; Uterine Neoplasms; Vincristine | 2016 |
Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line, Tumor; Drug Resistance, Neoplasm; Etoposide; Female; Flow Cytometry; Humans; Melanoma; Mice; Mice, SCID; Neoplasm Metastasis; Neoplastic Stem Cells; Skin Neoplasms; Xenograft Model Antitumor Assays | 2016 |
Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; C-Reactive Protein; Cisplatin; Etoposide; Fibrosis; Growth Differentiation Factor 15; Humans; Lung; Male; Middle Aged; Neoplasm Metastasis; Pneumonia; Testicular Neoplasms; Tomography, X-Ray Computed; Transforming Growth Factor beta1 | 2016 |
α-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin β1/β3 downregulation.
Topics: Anoikis; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cisplatin; Down-Regulation; Drug Synergism; Drug Therapy; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Integrin beta3; Lung Neoplasms; Neoplasm Metastasis; Paclitaxel; Reactive Oxygen Species; Thioctic Acid | 2016 |
Activity and safety of oral etoposide in pretreated patients with metastatic or recurrent thymic epithelial tumors (TET): A single-institution experience.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Glandular and Epithelial; Recurrence; Retreatment; Retrospective Studies; Thymus Neoplasms | 2016 |
A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Topics: Adolescent; Adult; Age of Onset; Antineoplastic Agents; Bleomycin; Brain Neoplasms; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Prognosis; Risk Assessment; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Young Adult | 2017 |
CXCR4 antagonists suppress small cell lung cancer progression.
Topics: Animals; Benzylamines; Carcinogenesis; Cell Line, Tumor; Cell Movement; Cisplatin; Cyclams; DNA-Binding Proteins; Drug Resistance, Neoplasm; Etoposide; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Mice, Knockout; Neoplasm Metastasis; Nuclear Proteins; Peptides; Receptors, CXCR4; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays | 2016 |
Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma.
Topics: Combined Modality Therapy; Etoposide; Humans; Ifosfamide; Myeloablative Agonists; Neoplasm Metastasis; Prospective Studies; Risk; Risk Factors; Sarcoma, Ewing; Stem Cell Transplantation; Transplantation, Autologous | 2008 |
Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dose Fractionation, Radiation; Etoposide; Female; Humans; Male; Medulloblastoma; Methotrexate; Neoplasm Metastasis; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2009 |
[Pulmonary resection in the management of gestational trophoblastic neoplasia: a clinical study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin, beta Subunit, Human; Combined Modality Therapy; Etoposide; Female; Follow-Up Studies; Gestational Trophoblastic Disease; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Pneumonectomy; Pregnancy; Prognosis; Retrospective Studies | 2008 |
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Bone Marrow; Caspase 8; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Cysteine Proteinase Inhibitors; Drug Resistance, Neoplasm; Enzyme Activation; Etoposide; Fenretinide; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Nude; Neoplasm Metastasis; Neuroblastoma; Reverse Transcriptase Polymerase Chain Reaction; TNF-Related Apoptosis-Inducing Ligand; Xenograft Model Antitumor Assays | 2009 |
Case report: Recurrence of a uterine tumor resembling ovarian sex-cord tumor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Laparotomy; Neoplasm Metastasis; Recurrence; Uterine Neoplasms | 2009 |
High-risk clinical stage I NSGCT: the case for RPLND.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lymph Node Excision; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Retroperitoneal Space; Risk Factors; Testicular Neoplasms | 2009 |
Case report: malignant teratoma of the uterine corpus.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans; Hysterectomy; Lymphatic Diseases; Lymphatic Metastasis; Neoplasm Metastasis; Teratoma; Treatment Outcome; Uterine Neoplasms | 2009 |
Local and systemic control of Ewing's bone sarcoma family tumors of the ribs.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Bone Plates; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Fascia Lata; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Neoadjuvant Therapy; Neoplasm Metastasis; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies; Ribs; Sarcoma, Ewing; Surgical Mesh; Thoracotomy; Vincristine | 2009 |
[Gastric metastasis from small cell lung cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Etoposide; Fatal Outcome; Female; Humans; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Pneumonia; Stomach Neoplasms; Vincristine | 2009 |
Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Etoposide; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Stomach Neoplasms; Taxoids; Treatment Failure | 2010 |
Growing teratoma syndrome of the ovary after fertility-sparing surgery and successful pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Etoposide; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Pregnancy; Teratoma | 2010 |
Orbital sarcoma with metastases at diagnosis: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiotherapy; Sarcoma; Treatment Outcome; Vincristine | 2010 |
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Ciprofloxacin; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Drug Antagonism; Drug Synergism; Drug Therapy, Combination; Etoposide; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Male; Mitoxantrone; Neoplasm Metastasis; Piperazines; Prostatic Neoplasms; Pyrimidines; Vinblastine | 2011 |
Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Radiotherapy Dosage; Retrospective Studies; Rhabdoid Tumor; Survival Rate; Teratoma; Treatment Outcome; Vincristine | 2010 |
Achievement of a continuous complete remission in a kidney transplant patient with advanced donor-derived small cell carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cadaver; Carboplatin; Carcinoma, Small Cell; Etoposide; Glomerulonephritis; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Male; Middle Aged; Neoplasm Metastasis; Tissue Donors | 2010 |
Expression of Slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin.
Topics: Animals; Apoptosis; Blotting, Western; Bone Marrow; Cell Line; Cell Line, Tumor; Chromatin Immunoprecipitation; Etoposide; Flow Cytometry; Humans; Introns; Mice; Mice, SCID; Neoplasm Metastasis; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Mas; Proto-Oncogene Proteins c-myb; Snail Family Transcription Factors; Transcription Factors | 2010 |
Infratentorial brain metastases of pediatric non-epithelial malignant tumors: three case reports.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Dactinomycin; Doxorubicin; Etoposide; Humans; Ifosfamide; Infant; Infratentorial Neoplasms; Irinotecan; Melphalan; Neoplasm Metastasis; Neuroblastoma; Rhabdomyosarcoma; Thiotepa; Topotecan; Vincristine | 2011 |
Sequential or concomitant chemotherapy in limited stage small-cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Proportional Hazards Models; Radiotherapy, Conformal; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate; Treatment Outcome | 2011 |
Cisplatinum combined with etoposide. Effective therapy for metastasised squamous-cell carcinoma of the cervix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Uterine Cervical Neoplasms | 2011 |
Mandibular ameloblastic carcinoma in a young patient.
Topics: Ameloblastoma; Biopsy; Bone Marrow; Carboplatin; Child; Etoposide; Female; Humans; Mandibular Neoplasms; Neoplasm Metastasis; Odontogenic Tumors; Pleural Effusion; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2012 |
Human chorionic gonadotropin (hCG) regression normograms for patients with high-risk gestational trophoblastic neoplasia treated with EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine) chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chorionic Gonadotropin; Cyclophosphamide; Dactinomycin; Drug Resistance, Neoplasm; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Vincristine | 2012 |
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Busulfan; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Melphalan; Myeloablative Agonists; Neoplasm Metastasis; Prognosis; Sarcoma, Ewing; Stem Cell Transplantation; Vincristine; Young Adult | 2012 |
[Young man with severe back pain].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Low Back Pain; Male; Neoplasm Metastasis; Orchiectomy; Testicular Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2012 |
Fatal cases of gestational trophoblastic neoplasia over four decades in the Netherlands: a retrospective cohort study.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Choriocarcinoma; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Guideline Adherence; Humans; Hydatidiform Mole; Hysterectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Netherlands; Practice Guidelines as Topic; Pregnancy; Retrospective Studies; Risk Assessment; Treatment Outcome; Uterine Neoplasms; Vincristine | 2012 |
Bleomycin, etoposide and cisplatinum (BEP) chemotherapy for metastatic germ cell tumours: treatment outcomes at UKM medical centre, Malaysia.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease-Free Survival; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Malaysia; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Retrospective Studies; Survival Rate; Treatment Outcome; Young Adult | 2012 |
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
Topics: Actins; Adenocarcinoma; Antineoplastic Agents; Cell Line, Tumor; Cell Membrane; Cell Movement; Cisplatin; Cytoskeleton; Etoposide; Guanine Nucleotide Exchange Factors; Humans; Myosin Light Chains; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Phosphorylation; Rho Guanine Nucleotide Exchange Factors; rho-Associated Kinases; rhoA GTP-Binding Protein; Stomach Neoplasms; Vincristine | 2012 |
Treatment update in small-cell lung cancer: from limited to extensive disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel; Small Cell Lung Carcinoma; Topotecan | 2012 |
Neuroendocrine carcinoma of the pancreas with soft tissue metastasis.
Topics: Adult; Carcinoma, Neuroendocrine; Cisplatin; Etoposide; Humans; Laparotomy; Male; Neoplasm Metastasis; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Phosphopyruvate Hydratase; Positron-Emission Tomography; Soft Tissue Neoplasms; Splenectomy; Tomography, X-Ray Computed; Treatment Outcome | 2012 |
Microparticle-associated tissue factor activity in plasma is unaffected by cytolytic chemotherapy treatment in metastatic testicular cancer patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell-Derived Microparticles; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Testicular Neoplasms; Thromboplastin | 2013 |
Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infant; Male; Mesna; Neoplasm Metastasis; Remission Induction; Sarcoma; Sarcoma, Ewing; Soft Tissue Neoplasms; Treatment Outcome; Vincristine | 2002 |
Effects of ER-37328 on primary tumor, liver metastasis, and life span in a murine colon 38 orthotopic transplantation model.
Topics: Animals; Carbazoles; Cell Division; Colonic Neoplasms; Etoposide; Female; Humans; Liver Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Neoplasm Metastasis; Pyrimidines; Survival Analysis; Time Factors; Transplantation, Heterologous | 2003 |
[Inhibitory Effects of Etoposide Combined with 8-methoxypsoral en on Highly Metastatic Human Mucoepidermoid Carcinoma Cells].
Topics: Carcinoma, Mucoepidermoid; Cell Division; Drug Synergism; Etoposide; Humans; Methoxsalen; Neoplasm Metastasis; Tumor Cells, Cultured | 1999 |
Effect of a novel somatostatin analogue combined with cytotoxic drugs on human tumour xenografts and metastasis of B16 melanoma.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Disease Models, Animal; Drug Therapy, Combination; Etoposide; Humans; Lymphoma; Male; Melanoma, Experimental; Mice; Mice, Inbred CBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Peptides, Cyclic; Somatostatin; Xenograft Model Antitumor Assays | 2003 |
Multiple relapses of mature teratoma, germinal and non-germ cell cancer in a patient treated with chemotherapy for testicular non-seminomatous germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Peritoneal Neoplasms; Teratoma; Testicular Neoplasms | 2003 |
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cohort Studies; Disease Progression; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Receptors, Estrogen; Time Factors | 2003 |
Sterically stabilized etoposide liposomes: evaluation of antimetastatic activity and its potentiation by combination with sterically stabilized pentoxifylline liposomes in mice.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Etoposide; Female; Liposomes; Lung Neoplasms; Male; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Pentoxifylline | 2003 |
[Hereditary neuroendocrine gastroenteropancreatic tumors and multiple endocrine neoplasia type 1].
Topics: Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Catheter Ablation; Cisplatin; Clinical Trials as Topic; Doxorubicin; Etoposide; Gastrinoma; Gastrointestinal Agents; Humans; Insulinoma; Interferon-alpha; Multiple Endocrine Neoplasia Type 1; Neoplasm Metastasis; Octreotide; Omeprazole; Palliative Care; Pancreatectomy; Pancreatic Neoplasms; Prospective Studies; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Somatostatin; Streptozocin; Time Factors; Zollinger-Ellison Syndrome | 2004 |
Results of cisplatin, adriamycin and etoposide chemotherapy in patients with recurrent and metastatic endometrial cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endometrial Neoplasms; Etoposide; Female; Humans; Medical Records; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2004 |
Pineal parenchymal tumours: I. Pineocytoma: a tumour responsive to platinum-based chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Diagnosis, Differential; Etoposide; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pineal Gland; Pinealoma; Spinal Neoplasms; Vincristine | 2004 |
Relationship between antiapoptotic molecules and metastatic potency and the involvement of DNA-dependent protein kinase in the chemosensitization of metastatic human cancer cells by epidermal growth factor receptor blockade.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Line, Tumor; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Synergism; Electrophoretic Mobility Shift Assay; ErbB Receptors; Etoposide; Genes, MDR; Humans; Indicators and Reagents; Melanoma; Neoplasm Metastasis; Nuclear Proteins; Protein Serine-Threonine Kinases; Pyrimidines; Pyrroles; Radiation-Sensitizing Agents; Rats | 2004 |
Placental site trophoblastic tumor: an overview.
Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Fertility; Humans; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Placenta Diseases; Pregnancy; Retrospective Studies; Treatment Outcome; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2004 |
Successful treatment of an unresectable choroid plexus carcinoma in a patient with Li-Fraumeni syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Child, Preschool; Choroid Plexus Neoplasms; Cyclophosphamide; Etoposide; Female; Humans; Li-Fraumeni Syndrome; Magnetic Resonance Imaging; Neoplasm Metastasis | 2005 |
Acquisition of anoikis resistance in human osteosarcoma cells does not alter sensitivity to chemotherapeutic agents.
Topics: Anoikis; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Separation; Cell Survival; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Extracellular Matrix; Flow Cytometry; Humans; Hypoxia; Neoplasm Metastasis; Osteosarcoma; Paclitaxel; Propidium; Vinblastine | 2005 |
Platinum-based chemotherapy in metastatic breast cancer: the Leicester (U.K.) experience.
Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Etoposide; Female; Humans; Middle Aged; Mitomycins; Neoplasm Metastasis; Neutropenia; Retrospective Studies; Salvage Therapy; Taxoids; Treatment Outcome; United Kingdom; Vinblastine | 2005 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
[Comparing cisplatin plus etoposide with combination of mitomycin, ifosfamide and cisplatin in advanced non-small cell lung cancer patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Treatment Outcome; Turkey | 2006 |
Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Illinois; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Retrospective Studies; Survival Analysis; Treatment Outcome; Uterine Neoplasms; Vincristine | 2006 |
Management of gestational trophoblastic neoplasia with metastasis to the central nervous system: A 12-year review at the Philippine General Hospital.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Etoposide; Female; Gestational Trophoblastic Disease; Humans; Injections, Spinal; Medical Records; Methotrexate; Middle Aged; Neoplasm Metastasis; Philippines; Pregnancy; Retrospective Studies; Survival Analysis; Uterine Neoplasms; Vincristine | 2006 |
Multiple granulocytic sarcomas in essential thrombocythemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Chromosome Deletion; Chromosomes, Human, Pair 7; Cytarabine; Etoposide; Fatal Outcome; Female; Femoral Fractures; Femoral Neoplasms; Humans; Hydroxyurea; Middle Aged; Mitobronitol; Neoplasm Metastasis; Nitrosourea Compounds; Primary Myelofibrosis; Radiography; Sarcoma, Myeloid; Thrombocythemia, Essential | 2006 |
Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Appendectomy; Appendiceal Neoplasms; Biomarkers, Tumor; Carcinoid Tumor; Cisplatin; Colectomy; Combined Modality Therapy; Diagnosis, Differential; Etoposide; Female; Fluorouracil; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Streptozocin | 2007 |
[Chemotherapy for metastatic germ cell tumours of the testis].
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cisplatin; Diagnosis, Differential; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Prognosis; Risk Factors; Seminoma; Testicular Neoplasms; Time Factors; Treatment Outcome | 2007 |
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO).
Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Etoposide; Fatal Outcome; Female; Hemangiosarcoma; Humans; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Platelet Count; Tomography, X-Ray Computed; Vincristine; Wilms Tumor | 2008 |
[A case of recurrent renal cell carcinoma which recurred after fourth surgical resection and survived for about 2 years by medroxyporgesterone acetate administration].
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Etoposide; Humans; Interferon-alpha; Interferon-gamma; Male; Medroxyprogesterone Acetate; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nephrectomy; Thiotepa | 2007 |
Successful multimodal treatment in a patient with thymoma accompanied by hepatic metastasis.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biopsy, Needle; Catheter Ablation; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Liver Neoplasms; Middle Aged; Myasthenia Gravis; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Thymectomy; Thymoma; Thymus Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Mediastinal Neoplasms; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Prognosis; Retroperitoneal Neoplasms; Salvage Therapy; Seminoma; Testicular Neoplasms; Treatment Outcome | 2007 |
Infectious complications from high-dose chemotherapy and autologous stem cell transplantation for metastatic germ cell tumors.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Infections; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Paclitaxel; Premedication; Retrospective Studies; Transplantation, Autologous | 2008 |
Adriamycin, cyclophosphamide, and etoposide (VP-16-213) in extensive-stage small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1984 |
Reversal of recurrent laryngeal nerve palsy following VP16-213 combination therapy in a patient with metastatic teratoma of the testis.
Topics: Adult; alpha-Fetoproteins; Bleomycin; Cisplatin; Drug Therapy, Combination; Etoposide; Humans; Laryngeal Nerves; Male; Neoplasm Metastasis; Podophyllotoxin; Recurrent Laryngeal Nerve; Teratoma; Testicular Neoplasms; Vocal Cord Paralysis | 1982 |
Chemotherapy of primary (in situ) testicular tumours: response in advanced metastatic disease.
Topics: Abdomen; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms; Vinblastine | 1983 |
VP16-213, cisplatinum, and adriamycin salvage therapy of refractory and/or recurrent nonseminomatous germ cell neoplasms.
Topics: Adolescent; Adult; Cisplatin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Podophyllotoxin; Testicular Neoplasms | 1982 |
Etoposide infusions for treatment of metastatic lung cancer.
Topics: Carcinoma, Small Cell; Chromatography, High Pressure Liquid; Etoposide; Follow-Up Studies; Humans; Infusions, Parenteral; Kinetics; Lung Neoplasms; Neoplasm Metastasis; Podophyllotoxin | 1984 |
High-dose etoposide for refractory malignancies: a phase I study.
Topics: Adult; Aged; Bone Marrow; Diarrhea; Drug Evaluation; Erythema; Etoposide; Female; Humans; Male; Middle Aged; Mouth Diseases; Neoplasm Metastasis; Neoplasms; Paresthesia; Podophyllotoxin; Reflex | 1984 |
VP16-213 and cyclophosphamide in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Breast Neoplasms; Cyclophosphamide; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Etoposide; Female; Humans; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Prognosis | 1983 |
In vitro cytotoxicity of VP 16 on primary tumor and metastasis of Lewis lung carcinoma.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Etoposide; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms, Experimental; Podophyllotoxin; Thymidine | 1982 |
Adriamycin and VP16-213 combination treatment for breast cancer previously treated by the CMF regimen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Podophyllotoxin | 1982 |
Phase II study of VP16-213 (etoposide) in refractory metastatic breast carcinoma.
Topics: Adult; Aged; Breast Neoplasms; Drug Evaluation; Drug Resistance; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin | 1982 |
Retroviral mediated transfer of the human multidrug resistance gene (MDR-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Clinical Protocols; Drug Resistance; Etoposide; Genetic Vectors; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Informed Consent; Interleukin-3; Interleukin-6; Mesna; Middle Aged; Neoplasm Metastasis; Paclitaxel; Pancytopenia; Recombinant Fusion Proteins; Recombinant Proteins; Retroviridae; Stem Cell Factor; Transplantation, Autologous; Vinblastine | 1994 |
Natural killer cell activity in long-term survivors of testicular cancer. Influence of cytostatic therapy and initial stage of disease.
Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Etoposide; Humans; Killer Cells, Natural; Male; Multivariate Analysis; Neoplasm Metastasis; Testicular Neoplasms | 1995 |
Germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Germinoma; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Orchiectomy; Salvage Therapy; Testicular Neoplasms; Vinblastine | 1994 |
[Germ cell tumors of the testis: current status and future progress].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Follow-Up Studies; Germinoma; Humans; Male; Moscow; Neoplasm Metastasis; Russia; Seminoma; Testicular Neoplasms; Time Factors; USSR | 1995 |
[Etoposide, epirubicin and cisplatin (EEP) combination in metastatic cancers of the cardia and the stomach. Groupe de recherche en cancérologie du Nord (GRECNO)].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Epirubicin; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Treatment Outcome | 1994 |
Gestational trophoblastic disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Administration Schedule; Etoposide; Female; Humans; Hydatidiform Mole; Leucovorin; Methotrexate; Neoplasm Metastasis; Neoplasm Staging; Pregnancy; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 1994 |
[Comparison of the effectiveness and toxicity of parenteral and oral vepesid in the treatment of disseminated breast cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Injections, Intravenous; Lymphatic Metastasis; Middle Aged; Neoplasm Metastasis; Time Factors | 1995 |
The choriocarcinoma syndrome: an emergency.
Topics: Adult; Choriocarcinoma; Cisplatin; Emergencies; Etoposide; Female; Humans; Male; Neoplasm Metastasis; Radiography, Thoracic; Retroperitoneal Neoplasms; Syndrome | 1995 |
[Small cell bronchial cancer in a 17-year-old young man].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Neoplasm Metastasis; Pneumonectomy | 1994 |
Enhanced therapeutic effects of anti-tumour agents against growth and metastasis of colon carcinoma 26 when given in combination with interferon and interleukin-2.
Topics: Animals; Carcinoma; Cisplatin; Colonic Neoplasms; Drug Therapy, Combination; Etoposide; Interferon-beta; Interleukin-2; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Neoplasm Metastasis | 1994 |
Etoposide for metastatic breast cancer.
Topics: Breast Neoplasms; Etoposide; Humans; Neoplasm Metastasis; Remission Induction | 1994 |
The prognostic significance of bone marrow metastases in small cell lung cancer patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Prognosis; Proportional Hazards Models; Survival Analysis | 1993 |
Amendment to clinical research projects. Genetic marking with retroviral vectors to study the feasibility of stem cell gene transfer and the biology of hematopoietic reconstitution after autologous transplantation in multiple myeloma, chronic myelogenous
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Breast Neoplasms; Cisplatin; Clinical Protocols; Combined Modality Therapy; Cyclophosphamide; Etoposide; Feasibility Studies; Genetic Therapy; Genetic Vectors; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melphalan; Multiple Myeloma; Neoplasm Metastasis; Retroviridae; Transfection; Transplantation, Autologous; Whole-Body Irradiation | 1993 |
Chemotherapy combined with surgery in the treatment of gestational trophoblastic disease (GTD).
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Hydroxyurea; Hysterectomy; Lung Neoplasms; Methotrexate; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Pregnancy; Salvage Therapy; Thoracotomy; Treatment Outcome; Trophoblastic Neoplasms; Uterine Hemorrhage; Uterine Neoplasms; Vincristine | 1993 |
Etoposide treatment in recurrent medulloblastoma.
Topics: Adult; Brain Neoplasms; Child; Child, Preschool; Etoposide; Female; Frontal Lobe; Humans; Male; Medulloblastoma; Neoplasm Metastasis; Prognosis; Recurrence; Spinal Cord Neoplasms; Tomography, X-Ray Computed; Treatment Outcome | 1994 |
Dose-intensive chemotherapy with etoposide-cyclophosphamide for advanced breast cancer. North American Marrow Transplant Group.
Topics: Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-3; Middle Aged; Neoplasm Metastasis; Recombinant Proteins; Thrombocytopenia; Treatment Outcome | 1996 |
Metastatic neuroblastoma in children older than one year: prognostic significance of the initial metaiodobenzylguanidine scan and proposal for a scoring system.
Topics: 3-Iodobenzylguanidine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Etoposide; Female; Humans; Infant; Iodine Radioisotopes; Iodobenzenes; Lymphatic Metastasis; Male; Neoplasm Metastasis; Neuroblastoma; Predictive Value of Tests; Prognosis; Remission Induction; Retrospective Studies; Survival Rate; Tomography, Emission-Computed | 1996 |
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Breast Neoplasms; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leukapheresis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Thiotepa | 1995 |
High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Pregnancy; Prognosis; Testicular Neoplasms; Trophoblastic Neoplasms; Uterine Neoplasms | 1995 |
Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Castration; Drug Resistance; Epirubicin; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Survival Rate | 1996 |
Testis conservation studies in germ cell cancer justified by improved primary chemotherapy response and reduced delay, 1978-1994.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Retrospective Studies; Seminoma; Testicular Neoplasms; Time Factors; Treatment Outcome | 1996 |
Treatment of men with metastatic non-seminomatous germ cell tumours with cyclical POMB/ACE chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Germinoma; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Survival Rate; Testicular Neoplasms; Vincristine | 1997 |
High-dose cyclophosphamide, etoposide and carboplatin with autologous bone marrow support for metastatic breast cancer: long-term results.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carboplatin; Cyclophosphamide; Etoposide; Humans; Middle Aged; Neoplasm Metastasis; Survival Rate; Transplantation, Autologous | 1998 |
Monocyte chemoattractant protein-1 gene modification of multidrug-resistant human lung cancer enhances antimetastatic effect of therapy with anti-P-glycoprotein antibody in SCID mice.
Topics: Animals; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Chemokine CCL2; Clone Cells; Drug Resistance, Multiple; Etoposide; Humans; Immunotherapy; Lung Neoplasms; Mice; Mice, SCID; Neoplasm Metastasis; Organ Specificity; Recombinant Proteins; Transfection; Tumor Cells, Cultured | 1999 |
Dose-intensive chemotherapy for breast cancer with brain metastases: a case series.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carboplatin; Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Neoplasm Metastasis; Remission Induction; Survival Analysis; Thiotepa | 1999 |
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Germany; Germinoma; Humans; Ifosfamide; Male; Matched-Pair Analysis; Multivariate Analysis; Neoplasm Metastasis; Prognosis; Survival Rate; United States | 1999 |
Histology and sensitivity to anticancer drugs of two human non-small cell lung carcinomas implanted in the pleural cavity of nude mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Doxorubicin; Ellipticines; Etoposide; Female; Gemcitabine; Humans; Lung Neoplasms; Lymphatic Metastasis; Mice; Mice, Nude; Neoplasm Metastasis; Paclitaxel; Pleural Neoplasms; Topotecan; Transplantation, Heterologous; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2000 |
p53 regulates the expression of the tumor suppressor gene maspin.
Topics: Adenoviridae; Antineoplastic Agents; Breast Neoplasms; DNA Damage; DNA-Binding Proteins; Etoposide; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Humans; Male; Neoplasm Metastasis; Promoter Regions, Genetic; Prostatic Neoplasms; Proteins; RNA, Messenger; Serpins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Ultraviolet Rays | 2000 |
Activation of the tumor metastasis suppressor gene, KAI1, by etoposide is mediated by p53 and c-Jun genes.
Topics: 5' Untranslated Regions; Antigens, CD; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Etoposide; Gene Expression; Genes, Reporter; Humans; Kangai-1 Protein; Lung Neoplasms; Male; Membrane Glycoproteins; Neoplasm Invasiveness; Neoplasm Metastasis; Prostatic Neoplasms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-jun; Regulatory Sequences, Nucleic Acid; Transcription Factor AP-1; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2000 |
[Hemorrhagic diathesis as initial symptom of stomach carcinoma].
Topics: Algorithms; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Neoplasms; Carcinoma, Signet Ring Cell; Cisplatin; Diagnosis, Differential; Disseminated Intravascular Coagulation; Etoposide; Female; Fluorouracil; Hemorrhagic Disorders; Humans; Leucovorin; Middle Aged; Neoplasm Metastasis; Precancerous Conditions; Stomach; Stomach Neoplasms; Thrombocytopenia | 2000 |
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |
P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; bcl-2-Associated X Protein; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Germinoma; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Testicular Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53 | 2001 |
Central nervous system involvement in gestational trophoblastic neoplasia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chorionic Gonadotropin, beta Subunit, Human; Cyclophosphamide; Dactinomycin; Etoposide; Female; Humans; Methotrexate; Middle Aged; Neoplasm Metastasis; Pregnancy; Prospective Studies; Survival Analysis; Tomography, X-Ray Computed; Trophoblastic Neoplasms; Uterine Neoplasms; Vincristine | 2001 |
Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Topics: Adrenal Gland Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Marrow Examination; Bone Marrow Transplantation; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Life Tables; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Staging; Neoplasm, Residual; Neuroblastoma; Prognosis; Retroperitoneal Neoplasms; RNA, Messenger; RNA, Neoplasm; Survival Analysis; Treatment Outcome; Tyrosine 3-Monooxygenase; Vincristine | 2001 |
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Neoplasm Metastasis; Quinolines; Vincristine; Xenograft Model Antitumor Assays | 2001 |
[Typical forms of choriocarcinoma in clinical practice--diagnosis and therapeutic course in four patients].
Topics: Abortion, Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Choriocarcinoma; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pregnancy; Radiography; Uterine Neoplasms | 2001 |
Experience in treatment of metastatic pulmonary carcinoid tumors.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Cisplatin; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Retrospective Studies; Somatostatin; Streptozocin; Survival Analysis | 2001 |
Testicular germ cell tumor with rhabdomyosarcoma successfully treated by disease-adapted chemotherapy including high-dose chemotherapy: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carboplatin; Cell Differentiation; Cisplatin; Combined Modality Therapy; Diphosphonates; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Lumbar Vertebrae; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Multiple Primary; Orchiectomy; Pamidronate; Remission Induction; Rhabdomyosarcoma; Seizures; Seminoma; Spinal Neoplasms; Teratoma; Testicular Neoplasms; Transplantation, Autologous | 2001 |
Curing metastatic testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Humans; Male; Neoplasm Metastasis; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2002 |
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Topics: Administration, Oral; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD56 Antigen; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Humans; Male; Middle Aged; Mitotane; Neoplasm Metastasis; Rhodamines; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Total-body hyperthermia with and without chemotherapy for advanced human neoplasms.
Topics: Adult; Antineoplastic Agents; Bone Marrow; Burns; Creatine Kinase; Electroencephalography; Etoposide; Female; Humans; Hyperthermia, Induced; L-Lactate Dehydrogenase; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Neoplasms; Peripheral Nervous System Diseases; Remission, Spontaneous; Tachycardia | 1979 |
[Clinical and therapeutic study (phase II) using VP-16/213 and methyl-CCNU in patients with inoperable, recurring or metastasizing carcinomas of the gastriointestinal tract].
Topics: Adult; Aged; Colonic Neoplasms; Drug Therapy, Combination; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Stomach Neoplasms; Terminal Care; Time Factors | 1978 |
VP-16, cyclophosphamide, adriamycin and cis-platinum (V:CAP-I) in patients with metastatic adenocarcinoma of the lung.
Topics: Adenocarcinoma; Adult; Aged; Bone Marrow; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Time Factors; Vomiting | 1979 |
[VP 16-213 in combination with endoxan, methotrexate and oncovin as polychemotherapy for bronchogenic carcinoma].
Topics: Adenocarcinoma; Anaplasia; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Etoposide; Humans; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Podophyllotoxin; Remission, Spontaneous; Vincristine | 1977 |
Effect of hemostasis modifiers of the activity of VP 16 213 on Lewis lung carcinoma.
Topics: Animals; Aspirin; Etoposide; Hemostasis; Heparin; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Transplantation, Homologous | 1977 |
Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.
Topics: Animals; Etoposide; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Solvents; Teniposide; Time Factors | 1976 |
A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lung Neoplasms; Methotrexate; Neoplasm Metastasis; Pilot Projects; Recurrence; Treatment Outcome; Vincristine | 1992 |
[Pilot phase II trial of high-dose etoposide combined with cisplatin in the treatment of refractory lung cancer].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Sarcoma | 1992 |
Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Pilot Projects; Prednisolone | 1992 |
Ewing's sarcoma: experience with 12 cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Sarcoma, Ewing; Vincristine | 1992 |
Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Vincristine | 1991 |
[Complete remission of a highly malignant, progressive under therapy Wilm's tumor using the combination carboplatin and etoposide (VP 16)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child, Preschool; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Female; Humans; Kidney Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Nephrectomy; Remission Induction; Wilms Tumor | 1991 |
Treatment of bladder carcinoma using a germ cell chemotherapy protocol.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Carcinoembryonic Antigen; Carcinoma, Transitional Cell; Chorionic Gonadotropin; Cisplatin; Etoposide; Humans; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Urinary Bladder Neoplasms; Vincristine | 1990 |
The growth rate of metastatic nonseminomatous germ cell testicular tumours measured by marker production doubling time--II. Prognostic significance in patients treated by chemotherapy.
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chorionic Gonadotropin; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Germ Cell and Embryonal; Prognosis; Testicular Neoplasms; Time Factors | 1990 |
High-dose carboplatinum and VP-16 in treatment of metastatic adrenal carcinoma.
Topics: Adrenal Cortex Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cushing Syndrome; Diagnosis, Differential; Etoposide; Humans; Infant; Male; Neoplasm Metastasis; Radiography | 1991 |
Chemotherapy of disseminated Merkel-cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Merkel Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Remission Induction; Skin Neoplasms; Survival Rate; Vincristine | 1991 |
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Combined Modality Therapy; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Mitoxantrone; Neoplasm Metastasis; Neoplasm Recurrence, Local; Survival Rate; Thiotepa; Transplantation, Autologous | 1990 |
Chemotherapy for metastatic non-small-cell lung cancer. A case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis | 1990 |
Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Leukopenia; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasm Metastasis; Remission Induction; Thrombocytopenia | 1990 |
Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carboplatin; Carcinoembryonic Antigen; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Neoplasm Metastasis; Organoplatinum Compounds; Prognosis; Recurrence; Serpins; Uterine Cervical Neoplasms | 1990 |
[Study on etoposide therapy of relapsing prostatic cancer patients].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Drug Administration Schedule; Drug Evaluation; Etoposide; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Prostatic Neoplasms | 1990 |
Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study.
Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Prospective Studies | 1990 |
Testicular cancer and the legacy of chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Male; Neoplasm Metastasis; Prognosis; Risk; Testicular Neoplasms; Vinblastine | 1985 |
Cisplatin and etoposide salvage therapy and resection of the residual tumor in pretreated germ cell testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Dysgerminoma; Etoposide; Humans; Male; Mesonephroma; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Teratoma; Testicular Neoplasms | 1985 |
Small cell carcinoma of the ovary: a rapidly lethal tumor occurring in the young.
Topics: Adolescent; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Child; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Microscopy, Electron; Neoplasm Metastasis; Ovarian Neoplasms; Vinblastine; Vincristine | 1985 |
Combination chemotherapy with bleomycin, etoposide, and cisplatin in metastatic non-small-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Time Factors | 1985 |
Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Doxorubicin; Etoposide; Humans; Male; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Germ Cell and Embryonal; Risk; Teratoma; Testicular Neoplasms; Testis; Time Factors; Vinblastine | 1986 |
Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Humans; Male; Neoplasm Metastasis; Paresthesia; Peripheral Nervous System Diseases; Raynaud Disease; Testicular Neoplasms; Time Factors; Vinblastine | 1986 |
Transient tumor marker elevation following chemotherapy for germ cell tumors of the testis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Orchiectomy; Teratoma; Testicular Neoplasms; Tomography, X-Ray Computed | 1986 |
Thymic rebound in an adult following chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Etoposide; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Testicular Neoplasms; Thymectomy; Thymus Hyperplasia; Tomography, X-Ray Computed | 1986 |
Cisplatin-based treatment of adrenocortical carcinoma.
Topics: Adrenal Cortex Neoplasms; Adrenocorticotropic Hormone; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local | 1987 |
Altered renin and aldosterone excretion in patients treated for metastatic germ cell tumours.
Topics: Aldosterone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Kidney; Male; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal; Renin; Testicular Neoplasms; Vinblastine | 1987 |
Clinical predictors of response in metastatic germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Dactinomycin; Etoposide; Humans; Male; Neoplasm Metastasis; Prognosis; Retrospective Studies; Testicular Neoplasms; Vinblastine | 1988 |
Etoposide and mitomycin-C in pretreated metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Etoposide; Female; Follow-Up Studies; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis | 1989 |
Phase II pilot study with cisplatin, etoposide, and continuous-infusion 5-fluorouracil in metastatic non-small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Evaluation; Electrocardiography; Etoposide; Female; Fluorouracil; Heart; Humans; Lung Neoplasms; Male; Neoplasm Metastasis | 1987 |
Etoposide admixed with cisplatin. Phase I clinical investigation of 72-hour infusion.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Creatinine; Drug Combinations; Drug Evaluation; Etoposide; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Remission Induction | 1989 |
Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Podophyllotoxin; Thrombocytopenia; Vincristine | 1985 |
Etoposide and cisplatin salvage chemotherapy for small cell lung cancer.
Topics: Aged; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Etoposide; Female; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Neoplasm Metastasis; Platelet Count; Podophyllotoxin | 1985 |
Chemotherapy for gestational trophoblastic tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Choriocarcinoma; Chorionic Gonadotropin; Cisplatin; Dactinomycin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Humans; Hydatidiform Mole; Luteinizing Hormone; Methotrexate; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pregnancy; Pregnancy Complications, Neoplastic; Prognosis; Trophoblastic Neoplasms; Uterine Neoplasms | 1987 |
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Humans; Menopause; Methotrexate; Middle Aged; Neoplasm Metastasis; Receptors, Estrogen | 1988 |
Intensive chemotherapy including cisplatin with or without etoposide for children with soft-tissue sarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Etoposide; Female; Humans; Infant; Male; Neoplasm Metastasis; Patient Compliance; Remission Induction; Rhabdomyosarcoma; Soft Tissue Neoplasms; Time Factors; Vincristine | 1987 |
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine | 1986 |
Treatment of metastatic adrenal cortical carcinoma with cisplatin and etoposide (VP-16).
Topics: Adrenal Cortex Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Etoposide; Female; Humans; Male; Mitotane; Neoplasm Metastasis | 1986 |
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Evaluation; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms | 1987 |